What’s Worse Than a Pandemic? A Twindemic

1

On the record of issues to fret about within the age of SARS-CoV-2, boring, outdated winter flu most likely doesn’t rank extremely. Particularly not in the course of a summer season warmth wave. And but it ought to.

Humanity has grown so accustomed to annual waves of influenza that it was the baseline comparability when Covid first arrived. (It’ll be simply one other flu, we stated.) The implication was that ranges of influenza illness, hospitalization and loss of life have been acceptable, even inevitable.

I used to be definitely responsible of that considering. Though my employer provides an annual flu shot, I typically didn’t hassle to get it. However the pandemic has uncovered the weak spot of our attitudes and insurance policies towards influenza. We now have a possibility to do issues otherwise. This isn’t an argument for flu-driven lockdowns or a nationwide paranoia about any bug. However we are able to construct higher defenses towards influenza at comparatively little value, and for a acquire in lives and health-care capability.

One purpose to get extra severe about flu is its value, each economically and in human phrases. Annual prices of treating influenza (routinely in extra of $10 billion within the U.S.) are vital, even whenever you simply have a look at hospital outlays for these most severely affected.

Influenza epidemics within the northern hemisphere have an effect on anyplace from 5% to fifteen% of the inhabitants yearly. On common, about 8% of the U.S. inhabitants get sick from flu every season. For many, it’s normally a light, if disagreeable expertise. However for some, it may be lethal.

The U.S. Facilities for Illness Management estimates that, on common, 36,000 folks have died of flu every year during the last decade, with 61,000 deaths within the 2017-2018 flu season. Within the U.Okay., the common is about 17,000 annual deaths. Clearly, Covid is a unique order of magnitude, however the prices to the health-care system from flu should not trivial.

The aged are most susceptible to flu, however so are pregnant ladies, very younger youngsters and people with different medical circumstances and weakened immune methods. Some who contract and recuperate from flu find yourself with post-viral signs that drag on. Lengthy Covid has confirmed us simply how debilitating these could be.

What occurs whenever you layer flu on high of Covid-19? We don’t actually know, since final winter noticed an extremely delicate flu season, principally as a consequence of measures equivalent to lockdowns, social distancing and masking. Infections charges for flu have been two-thirds decrease than in the course of the 2011-2012 season, which had file low charges.

We are able to’t depend on a repeat. The low prevalence of flu final 12 months makes it tougher to foretell which strains to incorporate on this winter’s vaccine. We might get fortunate once more, or issues might worsen: Lowered ranges of pure immunity after a couple of low-flu seasons might make it simpler for brand new variants to take maintain.

Britain, with its overstretched nationwide health-care system and gargantuan backlog of surgical procedures and different procedures, can scarcely afford a foul flu season. Consultations for influenza-like diseases take up substantial GP time and hospital capability in a standard 12 months. Excessive charges of flu on high of Covid can be a pressure too far, requiring substantial new authorities sources and leaving many individuals with out remedy.

However it’s not simply the compounded well being burden that ought to make us rethink influenza. The very fact is, we’ve got been far too complacent about flu for too lengthy. Many flu deaths are preventable with jabs and the sorts of behavioral modifications we’ve grown accustomed to from Covid.

Not solely did the social-distancing measures imposed in the course of the pandemic lower the unfold of flu, they’re additionally estimated to have led to a 20% drop within the widespread respiratory syncytial virus (RSV) within the U.S. RSV accounts for five% of the deaths in youngsters below 5 globally. The issue now, nonetheless, is that the current lifting of Covid restrictions has coincided with unseasonably excessive RSV circumstances within the U.S.

Larger ranges of flu vaccination can be a game-changer. Final winter, flu vaccine uptake in Britain reached file ranges, with the Nationwide Well being Service vaccinating greater than 80% of these over 65 — 10% increased than the earlier 12 months and forward of the World Well being Group purpose of 75% for the primary time.

However the vaccination price drops off with the younger. Lower than 45% of these below 65 with a number of underlying danger components will get vaccinated. Though greater than 2.5 million youngsters have been vaccinated by means of college packages, that’s nonetheless properly below half (47.5%) of all children. Uptake additionally varies throughout ethnic teams, with some minorities lagging in getting vaccines. Within the U.S., Black communities (the place vaccine charges are round 41%) had the best flu-related hospitalization price of any ethnicity.

A examine on the College of Bristol is presently searching for to find out what negative effects folks get when given the really useful flu vaccine together with both the Oxford/AstraZeneca or the Pfizer/BioNTech vaccines. Getting a joint Covid-19 booster shot and flu shot might guarantee that there’s extra flu vaccine protection.

In fact, the effectiveness of flu vaccines can range from one season to the following and from individual to individual. They’re usually between 40% and 60% efficient once they match up properly with the variants circulating.

So we’d be properly served to additionally apply our Covid habits to diseases like flu. Which may imply extra hybrid working throughout peak flu months or if there’s an outbreak. Masking at sure occasions, even when not obligatory, makes loads of sense too.

If Covid-19, like flu, goes to be a recurrent seasonal affliction — as appears possible — we might want to higher handle the stress on the well being methods in the course of the winter. Meaning being ready to finance increased ranges of care throughout these crunch intervals or doing extra to cut back the pressure on the system. We’ll most probably by no means remove influenza and different viruses, however we are able to make winters more cost effective and fewer depressing by elevating the bar on an sickness that many people handled too casually.

Source: What’s worse than a pandemic? A twindemic | Asia Post

.

Critics:

As public health officials look to fall and winter, the specter of a new surge of Covid-19 gives them chills. But there is a scenario they dread even more: a severe flu season, resulting in a “twindemic.”

Even a mild flu season could stagger hospitals already coping with Covid-19 cases. And though officials don’t know yet what degree of severity to anticipate this year, they are worried large numbers of people could forgo flu shots, increasing the risk of widespread outbreaks.

The concern about a twindemic is so great that officials around the world are pushing the flu shot even before it becomes available in clinics and doctors’ offices. Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention has been talking it up, urging corporate leaders to figure out ways to inoculate employees. The C.D.C. usually purchases 500,000 doses for uninsured adults but this year ordered an additional 9.3 million doses.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has been imploring people to get the flu shot, “so that you could at least blunt the effect of one of those two potential respiratory infections.”

The flu vaccine is rarely mandated in the U.S. except by some health care facilities and nursery schools, but this month the statewide University of California system announced that because of the pandemic, it is requiring all 230,000 employees and 280,000 students to get the flu vaccine by November 1.

According to the C.D.C., flu season occurs in the fall and winter, peaking from December to February, and so was nearing its end as the pandemic began to flare in the United States in March.

Vaccine mandates are controversial. They’re also effective.

Guam tries to revive tourism with vaccine vacations.

Chicago will require masks in school this fall, regardless of vaccination status.

‘The Hot Doctor’ Finds a Life Partner Close to Home

Fred Zalokar, Marathoner Who Took On Mountains, Is Found Dead in Yosemite

Three Men Charged in 2018 Missouri Duck Boat Accident

Buy My House, But I’m Taking the Toilet

Jury Awards $125 Million After Walmart Fires Woman With Down Syndrome

Opinion: Tear Down the Restaurant Sheds Before It’s Too Late

Stephen Colbert Agrees With Mitch McConnell

‘Incel’ Is Charged With Plotting to Shoot Women, U.S. Says

Is Patient Financing Right for Your Health Practice?

In these times of post-pandemic financial uncertainty, additional return on investment for medical providers is more welcome than ever. Patient financing — which for the purposes of this article means partnering with an external lender to provide service and procedure payments — can produce not just steady income for a practice, but help ensure that patients won’t have to put off procedures or, worse yet, abandon them altogether.

For example, Toronto Plastic Surgeons provides this facility to its patients through Medicard Patient Financing. There are also veterinary financing services for pets available through Medicard Patient Financing. What are some reasons practitioners might have employed in deciding upon this option?

No More Delays

There are, unfortunately, economic disparities when it comes to accessing healthcare services. Too often, the high-income and privileged have more access to healthcare resources than the medium- and low-income populations. Patient financing can help in reducing this imbalance, because the simple and daunting truth is that many medical problems don’t come announced, and it’s often impossible to plan for their associated expenses. With financing, patients don’t need to wait to get their accounts in order before opting for procedures — the result is, ideally, prompt and less stressful treatment.

Related: Fintech fuelling growth in Healthcare Financial Industry

Increased Patient Satisfaction

Since clients can often better manage their expenses via patient financing, they tend to be more satisfied on the whole. In part this is because they are not stressed and burdened with sudden financial decisions associated with urgent medical procedures. Better yet, they are more likely to stay loyal to a practice if they don’t have to worry as much. Compared to other practices that don’t offer this option, they are more likely to choose the former, which can mean increased business through word of mouth.

Reduced Collection Costs

When you partner with a patient financer, you receive payments on time. It also means that your team won’t spend needless hours and energy trying to collect payments.

Steady Cash Flow and Less Bad Debt

In setting up a conventional payment plan for a patient, your team is taking the responsibility of keeping tabs on payments and collecting them on time. It’s essentially extending a loan to a patient, typically without any interest. However, expenses like bills, payroll and lease/rent go on as usual. This can lead to tied up in , which will easily and quickly impact a budget. But when you opt for association with a patient financing company, the latter bears the cost of collections, including giving you the option of getting payment upfront.

Related: Healthcare is in Turmoil, But Technology Can Save Businesses Billions

Better Marketing

Association with a financing company with its own marketing arm can help promote a business — making your clinic stand out in comparison to competitors.

Which to Choose?

When it comes to financing models, three predominate. In the first, Self-Funding, you as the healthcare provider are responsible for receivables. From creating a payment schedule to collecting funds to following up with the patient, your team carries out all the tasks. In the Recourse Lending model, you work with a patient financier/lender, which will approve a patient’s loan after the business/practice passes qualifying criteria.

If the patient doesn’t pay, the lending/financing company will recover the losses from you. Among the drawbacks here is that the practice will have to bear the losses and lender’s fees. Lastly, there is the Non-Recourse Lending model. Similar to the second, you work with a lending company. Key differences are that it is the patient who has to pass the underwriting criteria (if the lender doesn’t approve the patient, no funding is provided by them), and that losses are borne by the lender. One disadvantage of this method is that the lenders charge interest from patients; when rates are high, patients might not be interested. Also, patients with a weak credit history might be rejected during the underwriting evaluation.

By : Chris Porteous / Entrepreneur Leadership Network Contributor – High Performance Growth Marketer

Source: Is Patient Financing Right for Your Health Practice?

.

Critics:

Publicly funded healthcare is a form of health care financing designed to meet the cost of all or most healthcare needs from a publicly managed fund. Usually this is under some form of democratic accountability, the right of access to which are set down in rules applying to the whole population contributing to the fund or receiving benefits from it.

The fund may be a not-for-profit trust that pays out for healthcare according to common rules established by the members or by some other democratic form. In some countries, the fund is controlled directly by the government or by an agency of the government for the benefit of the entire population. That distinguishes it from other forms of private medical insurance, the rights of access to which are subject to contractual obligations between an insured person (or their sponsor) and an insurance company, which seeks to make a profit by managing the flow of funds between funders and providers of health care services.

When taxation is the primary means of financing health care and sometimes with compulsory insurance, all eligible people receive the same level of cover regardless of their financial circumstances or risk factors.

Most developed countries have partially or fully publicly funded health systems. Most western industrial countries have a system of social insurance based on the principle of social solidarity that covers eligible people from bearing the direct burden of most health care expenditure, funded by taxation during their working life.

Among countries with significant public funding of healthcare there are many different approaches to the funding and provision of medical services. Systems may be funded from general government revenues (as in Canada, United Kingdom, Brazil and India) or through a government social security system (as in Australia, France, Belgium, Japan and Germany) with a separate budget and hypothecated taxes or contributions.

The proportion of the cost of care covered also differs: in Canada, all hospital care is paid for by the government, while in Japan, patients must pay 10 to 30% of the cost of a hospital stay. Services provided by public systems vary. For example, the Belgian government pays the bulk of the fees for dental and eye care, while the Australian government covers eye care but not dental care.

Publicly funded medicine may be administered and provided by the government, as in the Nordic countries, Portugal, Spain, and Italy; in some systems, though, medicine is publicly funded but most hospital providers are private entities, as in Canada. The organization providing public health insurance is not necessarily a public administration, and its budget may be isolated from the main state budget. Some systems do not provide universal healthcare or restrict coverage to public health facilities. Some countries, such as Germany, have multiple public insurance organizations linked by a common legal framework. Some, such as the Netherlands and Switzerland, allow private for-profit insurers to participate.

See also

Regeneron Says Antibody Therapy Prevents COVID-19 Infections

Regeneron Pharmaceuticals is planning to ask the Food and Drug Administration (FDA) to allow its antibody cocktail to be used as a preventive treatment for COVID-19, the company said Monday.

New results from a clinical trial conducted with the National Institute of Allergy and Infectious Diseases found the drug reduced the risk of symptomatic infection by 81 percent in people who were not infected at the start of the trial, Regeneron said.

The company has already received emergency use authorization from the FDA to use its antibody drugs to treat adults with mild to moderate COVID-19 and pediatric patients at least 12 years old who have tested positive for the virus and are at high risk of severe disease but are not yet hospitalized.

The trial enrolled 1,505 people who were not infected with the virus but lived in the same household as someone who recently tested positive. The patients were randomized to receive either one dose of the antibody therapy or a placebo administered as injections.

After 29 days, 11 people out of the 753 who received a single 1,200 mg dose of the treatment developed symptomatic COVID-19; 59 people who received a placebo out of 752 participants developed symptomatic COVID-19.

The drug provided 72 percent protection against symptomatic infections in the first week and 93 percent protection in subsequent weeks, Regeneron said. The data has not yet been peer reviewed or published.

Regeneron also said the trial found individuals treated with the therapy who experienced a symptomatic infection resolved their symptoms in one week, compared to three weeks with placebo. Infected individuals also cleared the virus faster with the therapy, the company said.

Adverse events occurred in 20 percent of patients who received the antibody drug and 29 percent of those who received a placebo, Regeneron said, but nobody withdrew from the trial because of them.

None of the participants who received the therapy were hospitalized or went to the ER because of COVID-19 over the course of 29 days; four in the placebo group did so. There were four deaths in the trial — two in the therapy group and two in the placebo group — but none were reported due to COVID-19 or the drug.

“With more than 60,000 Americans continuing to be diagnosed with COVID-19 every day, the REGEN-COV antibody cocktail may help provide immediate protection to unvaccinated people who are exposed to the virus, and we are also working to understand its potential to provide ongoing protection for immunocompromised patients who may not respond well to vaccines,” George Yancopoulos, president and chief scientific officer at Regeneron, said in a statement.

The trial tested the antibody treatment for use as a “passive vaccine,” which involves directly injecting antibodies into the body. Traditional vaccines rely on a person’s immune system to activate and develop its own antibodies.

That means the treatment may provide immediate benefits, in contrast to active vaccines, which take weeks to provide protection. In addition, using injections rather than an infusion could make administering it more convenient than the currently authorized use for antibody drugs.

While much of the attention has been focused on vaccines, experts say therapeutic treatments are just as important to ending the pandemic, which has killed more than 562,000 Americans.

Source: Regeneron says antibody therapy prevents COVID-19 infections | TheHill

.

.

The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work

Remdesivir in a syringe.

While clinical trials suggest remdesivir isn’t very effective in treating Covid-19, recent studies have shown that it does block Coronavirus activity. That apparent contradiction makes the antiviral drug even more controversial.

Remdesivir is an experimental drug developed by biotech company Gilead Sciences (under the brand name Veklury) in collaboration with the US Centers for Disease Control and Army Medical Research Institute of Infectious Diseases.

It’s one of many drug candidates that were originally designed in response to the threat from emerging diseases caused by RNA viruses — germs like the one behind the 2002 SARS outbreak — that have potential to cause global pandemics.

Such ‘broad-spectrum’ drugs target features shared by a wide range of disease-causing germs. In remdesivir’s case, that’s the virus’ genetic material, RNA. The drug proved ineffective against the Ebola virus, however, yet was still subsequently repurposed for SARS-CoV-2 coronavirus.

Remdesivir is not effective for Covid

News media prematurely reported that patients were responding to treatment. But the published data lated showed that “remdesivir was not associated with statistically significant clinical benefits [and] the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.”

.

.

As our special series On the Front Lines continues, NBC’s Joe Fryer profiles one of the country’s first COVID-19 patients, Raymond Sismaet, who spent nearly a month in a hospital before recovering. His story spotlights the antiviral drug remdesivir as a possible coronavirus treatment. » Subscribe to TODAY: http://on.today.com/SubscribeToTODAY » Watch the latest from TODAY: http://bit.ly/LatestTODAY About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day.
If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. Connect with TODAY Online! Visit TODAY’s Website: http://on.today.com/ReadTODAY Find TODAY on Facebook: http://on.today.com/LikeTODAY Follow TODAY on Twitter: http://on.today.com/FollowTODAY Follow TODAY on Instagram: http://on.today.com/InstaTODAY Follow TODAY on Pinterest: http://on.today.com/PinTODAY #Coronavirus #Remdesivir #TodayShow

.

.

The controversy surrounding remdesivir therefore revolves around whether the drug is actually an effective treatment. Early studies produced conflicting evidence on remdesivir’s effectiveness. Some found that Covid patients who received the drug recovered faster and fewer people died, but other studies showed that it didn’t reduce the length of hospitalization or death rate.

What’s weird about remdesivir is that it hasn’t been held to the same standards as other drug candidates. Covid-19 vaccines have been developed 10 times faster than traditional drugs, but they’ve passed the phase-3 clinical trials that test whether a potential medicine is both safe and effective in thousands of people.

Normally, a drug is only approved for use by a regulatory body like the US Food and Drug Administration if it meets the two criteria for safety and efficacy. Nonetheless, in October 2020, remdesivir was granted approval by FDA based on promising data from relatively small trials with about 1000 participants.

A large-scale analysis by the World Health Organization’s Solidarity trial consortium has cleared-up the confusion. Based on interim results from studying more than 5000 participants, the international study concluded that remdesivir “had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay.”

As a consequence of being mostly ineffective, WHO recommends against the use of remdesivir in Covid-19 patients.

Remdesivir is an expensive drug

The drug is administered over 5 or 10 days. A five-day course of treatment costs around $2600 per person. So for a hospital with hundreds of Covid patients, that would amount to millions of dollars for one antiviral.

That price could be cost-effective if remdesivir saved lives and its use was limited to moderate or severe disease, but it’s also being made available for milder cases and WHO found that it isn’t a lifesaving drug.

What next for remdesivir? Following WHO’s finding, an article in the British Medical Journal highlighted another antiviral as a cautionary tale: oseltamivir or ‘Tamiflu’ — a drug that aims to block the influenza virus.

During the early 2000s, governments started stockpiling Tamiflu, paying billions to its manufacturer, pharmaceutical firm Roche. Then in 2013, independent researchers gained access to Roche’s unpublished data, revealing that the drug caused many side effects and only shortened the duration of flu symptoms by a few hours.

Tamiflu only cost $75 per treatment and yet was still a massive waste of money. The BMJ article implies that the story of remdesivir is another scandal waiting to happen.

Given that remdesivir is expensive and doesn’t seem to save lives, does it have any value? Maybe — but not as a medicine itself. Recent research suggests scientists should at least keep studying how it works in order to develop better drugs.

Remdesivir does block Coronavirus

Remdesivir doesn’t prevent people from being infected by the SARS-CoV-2 virus.

Whereas a vaccine is designed prompt your immune system to recognize the spike protein that allows Coronavirus to invade cells — and protect people from infection — antivirals such as remdesivir aim to disrupt the virus’ ability to replicate, to slow its spread and give your body extra time to develop immunity.

Coronaviruses use RNA for their genetic material — not the DNA used by cells — which means that they need a special molecular machine to copy their genes when producing new virus particles. That machine, ‘RNA polymerase’, is what’s targeted by remdesivir.

Two studies have now revealed how remdesivir blocks SARS-CoV-2 at the molecular level.

First, chemical engineers at the University of Chicago found that remdesivir is better at reducing virus replication than two similar antivirals, ribavirin and favilavir. Their computer models suggest that remdesivir beats the other drugs because it’s the best at binding and destabilizing the RNA polymerase.

In the second new study, researchers at the University of Texas at Austin used ‘cryogenic-electron microscopy’ (cryo-EM) to take snapshots of the structure of the molecules involved in replication as they would interact in a Covid patient.

After adding remdesivir to RNA polymerase, cryo-EM images showed that the drug acts like a blockage in a photocopier, getting stuck in the RNA polymerase. When four molecules of remdesivir get between the gears of the polymerase machine, its copies of RNA ‘paper’ can no longer pass through, stalling the virus-copying process.

That leads us to why it’s worth studying remdesivir. As structural biologist David Taylor explains, “We were able to identify the point where that paper jam happens […] If we want to make the blockage even worse, we could do so.”

One of remdesivir’s flaws is its (possibly toxic) high dosage over a short timeframe, which contributes to adverse side effects. By tweaking the drug molecule’s structure, scientists may be able to make it block the RNA polymerase machine with fewer molecules, which would then allow the drug to be delivered in a smaller dose.

In fact, Gilead Sciences has already isolated a compound similar to remdesivir, GS-441524, which costs less and is easier to manufacture. It’s also simpler to administer: while remdesivir must be injected, GS-441524 could be ingested in pill form. More of the molecule reaches the lungs — the main site of infection — too, which led researchers to state that “GS-441524 is superior to remdesivir for Covid-19 treatment.”

As SARS-CoV-2’s genetic material mutates to create new strains of the virus — and variants of Covid-19 — we may need antivirals to buy us time if those new strains end-up evading our current vaccines.

So despite being expensive and ineffective at treating Covid, remdesivir’s true value could be to help researchers create more effective medicines.

Follow me on Twitter or LinkedIn. Check out my website or some of my other work here.

I’m a science communicator specialising in public engagement and outreach through entertainment, focusing on popular culture. I have a PhD in evolutionary biology and spent several years at BBC Science Focus magazine, running the features section and writing about everything from gay genes and internet memes to the science of death and origin of life. I’ve also contributed to Scientific American and Men’s Health. My latest book is ’50 Biology Ideas You Really Need to Know’

Source: The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work

.

.

More Contents:

Hospitals to provide Remdesivir to patients in Pune: official | Health
[…] Owing to the shortage of Remdesivir injections in Pune city, the administration has issued a notification stating that the drug wil […] Authorities have also started a new helpline for those who need Remdesivir […]
0
Delhi govt bans all gatherings except marriages & funerals till 30th April
newsonair.com – Today
[…] over 10 crore doses of COVID-19 vaccine in 85 days            Centre prohibits exports of injection Remdesivir & Active Pharmaceutical Ingredients of Remdesivir            Delhi govt bans all gatherings except marriages & funerals till 30th April           […]
0
CBI books former TMC MP for fraud : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
1
Remdesivir to be available for those in need: Nanded collector | Politics
Nanded has received 1,589 vials of Remdesivir, a key medicine in COVID-19 treatment, on Saturday and another 400 will arrive on Sunday, th […] There is a shortage of Remdesivir but efforts were on to tide over it, and a committee under the additional collector has been formed […]
0
COVID-19 in Chhattisgarh: Amid massive surge in cases, here’s what state Health Minister TS Singh Deo has to say about covid situation in state
[…] What is the status of vaccination and Remdesivir? Our vaccine stock will last for 2-3 days only. Meanwhile, we are running short of the Remdesivir antiviral vaccine and require immediate supply of the vaccine […]
0
Won’t allow Guru Teg Bahadur’s statue in Delhi, Sikh bodies tell Centre : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
12
Have only 5 days of vaccine left, Punjab CM tells Sonia at Covid review meet : The Tribune India
[…] 4 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
6
Lockdown not a solution to deal with Covid-19: Arvind Kejriwal | IndiaToday
[…] reports 10,250 new Covid cases in 24 hours Sun, 11 Apr, 2021 Centre halts export of anti-viral drug Remdesivir amid surge in Covid cases Sun, 11 Apr, 2021 Yogi Adityanath on battling second Covid wave […]
12
India bans export of COVID-19 treatment drug remdesivir
medicalxpress.com – Today
India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for th […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […] generic pharmaceutical producers based in India, Pakistan and Egypt, allowing them to manufacture remdesivir for distribution in 127 mostly low and lower-middle income nations […] Seven firms in India—the world’s biggest producer of generic drugs—are licensed to manufacture remdesivir […]
2
Day before procurement starts, trucks carrying illegal wheat from Bihar found in Bathinda : The Tribune India
[…] 3 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
58
RTPCR negative report mandatory for those coming to Chhattisgarh by rail, air route: CM Baghel instructs officials | Law-Order
[…] He has instructed the Chief Secretary that for smooth supply of Remdesivir injection in the state, senior officers should be sent to Hyderabad and Maharashtra fo […] this issue with the President of the Drug Association and asked him to increase the supply of Remdesivir Injection from other states […]
0
Lockdown Needed, But Decision After Wednesday: Maharashtra Minister Rajesh Tope
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […] in a meeting with the State Task Force discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
16
India finalises air bubble pact with Sri Lanka: Ministry : The Tribune India
[…] 3 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
1
Maha CM discusses strengthening of health infra with task force | Health
[…] plants, upgrading the number of beds and other medical facilities, besides availability of Remdesivir injections in a meeting held with members of the state COVID-19 task force […] The meeting also discussed how to stop the ”irrational use” of Remdesivir drug, which is in high demand for the treatment of COVID-19 patients […]
0
Maharashtra Covid task force feels ‘lockdown is required’, but decision only after 14 April
theprint.in – Today
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
N/A
Coronavirus latest news: South Africa variant can ‘break through’ Pfizer’s vaccine
[…] 4:46pm India bans export of Covid-19 treatment drug remdesivir India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand fo […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […]
N/A
Headlines now: Centre flags gaps in Covid containment measures of 3 states, and other top news
scroll.in – Today
[…] Centre bans export of antiviral drug Remdesivir amid surge in cases: The government said the ban will be in place till the Covid-19 situation i […]
1
Experts demand generic version of drug effective against Covid-19
[…] Among the medicines that have shown to work in Covid-19 are steroids and Remdesivir. The patent owner of Remdesivir, Gilead, had given voluntary licence to six Indian pharmaceuticals […] on rationalising the use of Remedesivir with strict adherence to the guidelines, making multiple Remdesivir stores or Remdesivir banks with strict sales control, and making racketeering of Remdesivir punishable under the Epidemic Act of India […]
1
Decision on Maharashtra lockdown after April 14: State Health Minister | Business Standard News
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
N/A
Enterprise Information | Inventory and Share Market Information – Information by Automobilnews.eu
automobilnews.eu – Today
The Centre has taken the step at a time when the nation is seeing a rising demand for Remdesivir injections attributable to a steep rise in COVID-19 circumstances within the wake of the secon […]
N/A
Nitin Gadkari calls up Sun Pharma’s chief to arrange Remdesivir injections for Nagpur | Indiablooms – First Portal on Digital News Management
[…] today Nitin Gadkari Image: PIB Nitin Gadkari calls up Sun Pharma’s chief to arrange Remdesivir injections for Nagpur India Blooms News Service | @indiablooms | 11 Apr 2021, 07:55 p […] India Blooms News Service | @indiablooms | 11 Apr 2021, 07:55 pm #NitinGadkari, #SunPharma, # Remdesivir, #Nagpur Nagpur/UNI: Union Minister Nitin Gadkari called up Sun Pharma’s chief to arrange fo […] With Maharashtra witnessing a spurt in COVID-19 cases, Remdesivir injections are in high demand in the state. Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patient […]
0
Remdesivir Shortage In Nagpur; Gadkari Dials Sun Pharma Chief
Remdesivir [Image: Reuters] Union minister Nitin Gadkari has called up Sun Pharma’s chief to arrange fo […] Union minister Nitin Gadkari has called up Sun Pharma’s chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra. Remdesivir is considered a key anti-viral drug in the fight against COVID-19, especially in adult patient […] over phone to inform him about the situation here and appealed to him to make available the Remdesivir injections […]
6
Appropriate decision on lockdown in Maha after April 14: Tope | Politics
[…] with the State Task Force, the chief minister discussed the availability of oxygen & beds, use of Remdesivir, treatment protocols, increase in capacity of facilities, imposition of restrictions & fines fo […]
0
India bans remdesivir exports as COVID-19 cases surge | India News | Al Jazeera
India has banned the export of antiviral drug remdesivir and its active pharmaceutical ingredients as demand rocketed amid a record surge in COVID-1 […] In addition to the remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] The World Health Organization in November issued a conditional recommendation against the use of remdesivir on hospitalised patients, regardless of disease severity, saying there was no evidence that th […]
13
India at third spot on Forbes billionaires’ list : The Tribune India
[…] 2 hours ago Govt prohibits exports of remdesivir till COVID situation improves in India Drugs inspectors, other officers directed to verify stocks, […]
4
India bans export of Covid-19 treatment drug remdesivir
India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for th […] Remdesivir, made by US pharma giant Gilead, was one of the first drugs to show relative promise in shortenin […] generic pharmaceutical producers based in India, Pakistan and Egypt, allowing them to manufacture remdesivir for distribution in 127 mostly low and lower-middle income nations […] firms in India — the world’s biggest producer of generic drugs — are licensed to manufacture remdesivir […]
N/A
Lack of testing, Covid appropriate behaviour not being followed in three states, says Centre
scroll.in – Today
[…] “Similarly, shortage of Remdesivir, Low Molecular Weight Heparin needs urgent attention in Korba District,” the central governmen […]
1
India bans exports of Remdesivir drug as new COVID-19 cases hit another record
thefinancialexpress.com.bd – Today
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
1
Centre bans exports of anti-viral drug Remdesivir
[…] The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves […] In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the statement said […] The government has taken the following steps to ensure easy access of hospital and patients to Remdesivir: 1. All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
2
SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
starpharma.com – Today
[…] very favourably with the selectivity index against SARS-CoV-2 reported in the literature of 279 for remdesivir and 55 for hydroxychloroquine […]
13
India bans Remdesivir exports as coronavirus rages on; rallies continue | MarketScreener
[…] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients, saying there was no evidence that the drug improved survival and othe […]
N/A
India bans Remdesivir exports as coronavirus rages on; rallies continue | Health
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients, saying there was no evidence that the drug improved survival and othe […]
0
Maharashtra: Decision on Covid lockdown after 14 April, says health minister Tope
The Maharashtra CM discussed several issues including availability of beds, use of Remdesivir and imposition of restrictions in today’s meeting The worst-hit Covid-19 state has administered over 1 crore vaccine doses state so far
7
India bans export of anti-viral drug Remdesivir amid surge in Covid cases
inquest.org.in – Today
[…] In the order, the government said it has banned the export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] To ensure more people can get Remdesivir, the government said manufacturers of Remdesivir have been asked to show on their website the details of their stockists and distributors […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir,” the government said. The National Clinical Management Protocol for COVID-19 lists Remdesivir as an investigational therapy, where informed and shared decision making is essential […]
5
India bans exports of antiviral drug Remdesivir as COVID-19 cases surge
NEW DELHI: India on Sunday (Apr 11) banned the export of antiviral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
N/A
Coronavirus Lockdown India News Live Updates: Covid-19 Cases, Lockdown, Night Curfew Guidelines in Delhi, UP, Maharashtra, MP Today Latest News
indianexpress.com – Today
[…] As Covid-19 cases continued to surge, Centre on Sunday banned the export of anti-viral drug remdesivir in view of increased demand, news agency PTI reported […] easy access of the drug, which is used in treatment of coronavirus, all domestic manufacturers of remdesivir have been requested to display details of their stockists and distributors on their website, th […] 13:52 (IST) 11 APR 2021 Two including nurse arrested for illegal Remdesivir sale The Crime Branch of Pune City police has arrested two persons, including a nurse from […]
3
Covid-appropriate behaviour not being followed in three states: Govt | Business Standard News
[…] Shortage of Remdesivir and low molecular weight Heparin needs urgent attention in Korba, the ministry said […]
1
Govt bans export of Remdesivir: Know all about the drug
[…] What is Remdesivir? Remdesivir is an investigational antiviral drug to fight Sars-cov 2, the virus that causes Covid-19 […] How did Remdesivir come into use? FDA had to issue an emergency use authorisation of Remdesivir to give doctors access to the medication outside of an investigational (clinical trial) setting […]
N/A
COVID appropriate behaviour not being followed in 50 most-affected districts in 3 states: Govt | Health
[…] Shortage of Remdesivir and low molecular weight Heparin needs urgent attention in Korba, the ministry said […]
0
Govt prohibits exports of remdesivir till COVID situation improves in India | India News,
indianexpress.com – Today
In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injectio […] which is used in treatment of coronavirus, to hospitals and patients, all domestic manufacturers of remdesivir have been advised to display on their website details of their stockists and distributors, th […] This has led to a sudden spike in demand for remdesivir injection used in treatment of COVID patients,” the ministry said […] “In light of the above, Government of India has prohibited the exports of remdesivir injection and remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” it said […]
10
Mathura’s Banke Bihari temple issues new guidelines amid surge in COVID-19 cases | India News • eeKPe News
news.eekpe.com – Today
[…] As India experiences a second wave of novel coronavirus infections, the demand for anti-viral drug Remdesivir has surged too. The Centre on… Read more India Bans Export Of Anti-Viral Drug Remdesivir Amid Surge In… INDIA eekpe – April 11, 2021 0 <!– –>7 Indian corporations are producing Remdesivir beneath voluntary licensing settlement with Gilead Sciences (File)New Delhi: India has banne […]
0
Doctors continue debate over ivermectin for COVID-19
[…] that only 16 deaths have been reported involving ivermectin, compared to much higher totals for remdesivir, which is used to treat COVID-19 symptoms, as well as COVID-19 vaccines […]
24
Can natural antioxidants help fight new GI symptoms in Covid patients?
yespunjab.com – Today
[…] (Agency) Covid Spike: India Prohibits Export Of Remdesivir – Advertisement – ShareFacebook Twitter Pinterest WhatsApp Linkedin Telegram Yes Punjab – TO […]
1
Covid spike: India prohibits export of remdesivir
[…] trend, the Ministry said: “There is a potential of further increase in demand of injection remdesivir and remdesivir active pharmaceutical ingredients (API) in the coming days […] of the above increasing Covid cases, Government of India has prohibited the exports of injection remdesivir and remdesivir active pharmaceutical ingredients (API) till the situation improves […] ” Govt of India prohibited exports of injection remdesivir and active pharmaceutical ingredients Seven Indian companies are producing injection remdesivir under voluntary licensing agreement with Gilead Sciences, US […]
0
India bans exports of anti-viral drug Remdesivir as Covid-19 cases surge
kathmandupost.com – Today
India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in Covid-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
0
India bans exports of Remdesivir drug as new Covid-19 cases hit another record, South Asia News & Top Stories
NEW DELHI (REUTERS) – India on Sunday (April 11) banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in Covid-1 […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for Covid-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,”Mr Rajesh Tope, health minister of India’ […]
3
India bans exports of Remdesivir drug as new Covid-19 cases hit another record
NEW DELHI (REUTERS) – India on Sunday (April 11) banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in Covid-1 […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for Covid-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,”Mr Rajesh Tope, health minister of India’ […]
1
Centre prohibits export of Injection Remdesivir in view of surge in COVID cases
[…] This has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients […] In light of the above, the Government of India has prohibited the export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves […] Government of India has taken the following steps to ensure easy access of hospital and patients to Remdesivir: All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
1
Vaccine universalisation, vaccine nationalism need of the hour: AAP leader Chadha writes to PM | Politics
[…] for all and taking steps like prohibiting COVID medicine export as it has today banned export of remdesivir injections,” he said […]
0
India bans export of Remdesivir amid rising Covid-19 cases
newsvibesofindia.com – Today
New Delhi (NVI): India has prohibited exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation improves, as the countr […] It said that there is a potential of further increase in the demand of Injection Remdesivir in the coming days. At present, seven Indian companies are producing Injection Remdesivir under voluntary licensing agreement with M/s […] In light of the above, India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves, the Ministry said […]
0
Maharashtra: Thane Covid centre patients shifted over oxygen concerns | Business Standard News
[…] as officer in charge to coordinate the purchase, storage and distribution of medical oxygen gas and Remdesivir injections, a release by civic spokesperson Sandeep Malavali said […]
N/A
India bans exports of Remdesivir drug as new COVID-19 cases hit another record | MarketScreener
[…] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
N/A
Maha: Thane COVID centre patients shifted over oxygen concerns | Health
[…] as officer in charge to coordinate the purchase, storage and distribution of medical oxygen gas and Remdesivir injections, a release by civic spokesperson Sandeep Malavali said […]
0
India Bans Exports of Antiviral Drug Remdesivir as COVID-19 Cases Surge
science.thewire.in – Today
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month.
2
India bans exports of Remdesivir drug as new COVID-19 cases hit another record | Health
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] In addition to the Remdesivir ban “till the situation improves”, the health ministry said in a statement that manufacturers ha […] media posts on Sunday showed large queues of people in the western state of Gujarat waiting to buy Remdesivir injections for COVID-19 patients. “Every day the central government is providing 50,000 Remdesivir injections but all of them are getting consumed,” Rajesh Tope, health minister of India’ […]
0
Amidst sharp rise in COVID-19 cases, India bans export of Remdesivir; its active pharmaceutical ingredients
asianews.press – Today
[…] As a result, it has led to a sudden spike in demand for Injection Remdesivir used in the treatment of COVID patients and the potential for a further increase in this demand i […] The Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) “till the situation improves in the country […] India govt has taken the following steps to ensure easy access of hospital and patients to Remdesivir: All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
1
No export of Remdesivir till COVID situation improves in India: Govt
New Delhi: In view of increased demand for Remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injectio […] which is used in treatment of coronavirus, to hospitals and patients, all domestic manufacturers of Remdesivir have been advised to display on their website details of their stockists and distributors, th […] This has led to a sudden spike in demand for Remdesivir injection used in treatment of COVID patients,” the ministry said […] “In light of the above, Government of India has prohibited the exports of remdesivir injection and remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” it said […]
0
India halts export of key Covid drug Remdesivir as cases rise across country
theprint.in – Today
Text Size: A- A+ New Delhi: The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves. Remdesivir is considered a key anti-viral drug in the fight against Covid-19 […] addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir. All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
N/A
Enterprise Information | Inventory and Share Market Information – Information by Automobilnews.eu
automobilnews.eu – Today
“Export of injection Remdesivir and Remdesivir Energetic Pharmaceutical Components (API) prohibited until the COVID-19 state of affairs within the […]
N/A
As coronavirus cases spike, Indore’s health infrastructure gets stretched | Business Standard News
[…] uploading videos and messages on social media about shortage of beds and key medicines like Remdesivir […] He said Remdesivir consignments were coming in at present and their distribution was taking place as per guidelines […] “Doctors have been told to give Remdesivir injections only to those who absolutely need it,” Satya said […]
2
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-1 […] sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said […] In addition to the Remdesivir ban “till the situation improves,” the health ministry said that manufacturers had been asked t […] The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalized patients, saying there was no evidence that the drug improved survival and othe […]
10
Covid-19: India bans export of Remdesivir injection, API
India today prohibited the export of Remdesivir injection, which is used to treat Covid patients, and also Remdesivir Active Pharmaceutical Ingredients (API), amidst a surge in coronavirus cases in the country […] “This has led to a sudden spike in the demand for injection Remdesivir used in treatment of Covid patients […] Seven Indian companies are producing the Remdesivir injection under voluntary licensing agreement with M/S Gilead Sciences of the USA […]
3
Maharashtra likely to announce 15-day lockdown after weekend curbs, marginal drop in Covid-19 cases after night curfew
[…] Other suggestions by Fadnavis like the early report of tests, availability of Remdesivir and oxygen for treatment will also be considered […]
1
“For God’s Sake, Get Vaccine, Drugs”: Top Mumbai Doctor’s Desperate Appeal
[…] The hospital was not only short of vaccines but also life-saving drugs like Remdesivir, said Dr Jalil Parkar, a pulmonary consultant with the hospital […] There is a shortage of Remdesivir, there is shortage of Tosilizubam […] “My earnest request for god’s sake please see to it that Remdesivir, Tosilizubam, vaccination — they are available […]
0
COVID-19: Centre bans exports of anti-viral drug Remdesivir till situation in India improves
COVID-19: Centre bans exports of anti-viral drug Remdesivir till situation in India improves India’s sudden spike in COVID-19 cases has led to an increase i […] Zee Media Updated: Apr 11, 2021, 06:29 PM IST The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves […] data on deaths In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the statement said […]
1
8k Remdesivir vials have arrived: Madhya Pradesh official as cases surge
[…] (Representational image: IE) Amid a surge in coronavirus cases and a clamour for Remdesivir, a drug considered useful in the treatment of the infection, a senior Madhya Pradesh official o […]
1
India bans Remdesivir exports till COVID surge abates
Seven Indian companies producing Remdesivir injections under voluntary licensing agreement with US-based Gilead Sciences have an installed capacity of about 38.80 lakh units per month
2
Government Halts Export Of Remdesivir Till COVID-19 Situation Improves
[…] The Government of India said: “Export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) prohibited till the COVID-19 situation in the countr […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir in India. Notably, there are seven Indian companies that are currently producing injection Remdesivir under voluntary licensing agreement with M/s Gilead Sciences, USA […]
6
Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. | Newsalert
Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. PTI | New Delhi | Updated: 11-04-2021 18:11 IST | Created: 11-04-2021 18:11 IST Export of anti-viral drug remdesivir prohibited in view of increased demand due to surge in COVID-19 cases: Centre. (This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.) POST / READ COMMENTS Country India Share
0
Clinical Research Forum Presents Moderna and Pfizer with Award for Extraordinary Impact on Health | NEWS-Line for Healthcare Professionals
[…] Hospital; Margaret Lippincott, MD, Instructor in Medicine, Massachusetts General Hospital · Remdesivir in COVID 19 – John Beigel, MD, Associate Director for Clinical Research, National Institute o […]
1
Centre bans export of Remdesivir amid crunch, eases access of Covid patients to anti-viral drug – Coronavirus Outbreak News
[…] being used in the treatment of Covid-19 patients, the Centre has prohibited the export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) […] In a press note on Sunday, the Centre prohibited exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API). A number of companies in India produce Injection Remdesivir under a voluntary licensing agreement with US pharma giant Gilead Sciences […]
3
For God’s Sake, Get Vaccine, Drugs: Top Mumbai Doctor’s Desperate Appeal
[…] The hospital was not only short of vaccines but also life-saving drugs like Remdesivir, said Dr Jalil Parkar, a pulmonary consultant with the hospital […] There is a shortage of Remdesivir, there is shortage of Tosilizubam […] “My earnest request for god’s sake please see to it that Remdesivir, Tosilizubam, vaccination — they are available […]
16
Government bans export of Remdesivir till Covid-19 situation improves
economictimes.indiatimes.com – Today
[…] In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] the government has also taken a few steps to ensure easy access of hospital and patients to Remdesivir. These steps are: – All domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […]
6
COVID-19: India bans export of Remdesivir drug, injection as coronavirus cases surge | India News
zeenews.india.com – Today
CORONAVIRUS COVID-19: India bans export of Remdesivir drug, injection as coronavirus cases surge The Centre banned the export of Remdesivir and its active pharmaceutical ingredients as the demand for anti-viral drug Remdesivir has surged […] As India experiences a second wave of novel coronavirus infections, the demand for anti-viral drug Remdesivir has surged too. The Centre on Sunday (April 11, 2021) banned the export of Remdesivir and its active pharmaceutical ingredients […]
16
India bans export of Remdesivir, its ingredients till COVID situation improves | Coronavirus News | Inshorts
inshorts.com – Today
india has banned the export of injection remdesivir and its active pharmaceutical ingredients api till the coronavirus situation in the country improves the centre said on sunday theres potential for further increase in demand for remdesivir in the coming days the government said adding that the …
0
Centre Bans Export of Remdesivir and Its Active Ingredients till Covid Crisis Eases in India
The Centre on Sunday prohibited the export of Remdesivir injection and its active pharmaceutical ingredients (API) till the pandemic situation arising ou […] The decision has been taken to ensure easy access of Remdesivir to infected patients and hospitals providing treating against the virus […] Several hospitals have complained of shortage of Remdesivir, considered a key anti-viral drug in the fight against COVID-19, especially in adult patients wit […] other steps to bring the situation under control, including advising all domestic manufactures of Remdesivir to display on their website, details of their stockists and distributors to facilitate access t […]
N/A
India bans export of Remdesivir injection amid surge in Covid cases | India News – Times of India
NEW DELHI: India on Sunday banned the export of Remdesivir injection till the Covid-19 situation improves in the country […] The government in a statement said that all domestic manufactures of Remdesivir have been advised to display on their website, details of their stockists/distributors t […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir […] The alarming spike in Covid cases in the country has led to a sudden increase in demand for the Remdesivir injection used in treating Covid patients […]
0
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
NEW DELHI: India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
0
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge | Reuters
[…] 1 MIN READ NEW DELHI (Reuters) – India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
2
India bans export of Remdesivir injection amid surge in Covid cases | India News – Times of India
timesofindia.indiatimes.com – Today
India News: NEW DELHI: India on Sunday banned the export of Remdesivir injection till the Covid-19 situation improves in the country.
19
No lockdown in Madhya Pradesh, only ‘corona curfew’, says CM | Business Standard News
[…] We have received 4,000 injections of Remdesivir (the key anti-viral drug) and would be getting 5,000 more today […]
N/A
Coronavirus: Centre bans export of antiviral drug Remdesivir amid surge in cases
scroll.in – Today
The Centre on Sunday banned the export of antiviral drug Remdesivir indefinitely, in view of the rising coronavirus cases in the country, ANI reported […] The government said the ban, which covers Remdesivir injections and Remdesivir active pharmaceutical ingredients, will be lifted only after there is an improvement in th […] Remdesivir is considered a key drug in combating Covid-19, especially in adult patients with sever […]
1
Gilead Sciences : India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge | MarketScreener
“In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a statement. Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month. (Reporting by Krishna N. Das and Devjyot Ghoshal; Editing by Susan Fenton)
0
Centre Prohibits Export of Remdesivir till COVID-19 Situation in Country Improves
Centre Prohibits Export of Remdesivir till COVID-19 Situation in Country Improves…
1
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge
mumbaimirror.indiatimes.com – Today
India bans exports of anti-viral drug Remdesivir as COVID-19 cases surge Reuters / Updated: Apr 11, 2021, 17:50 IST Representational Image […] Photo: BCCL New Delhi: India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent deman […] “In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a […]
7
Centre prohibits export of Remdesivir & its API till COVID-19 situation improves in India
With several states complaining of shortage of Remdesivir injections – which is used in COVID-19 treatment, the Centre on Sunday, has banned the export of Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation in the country improves […] READ | Remdesivir shortage in Nagpur; Union Minister Nitin Gadkari dials Sun Pharma chief Govt bans export of Remdesivir Additionally, Centre has taken the following steps to streamline Remdesivir supply: All domestic manufactures of Remdesivir have been advised to display on their website […]
15
Govt suspends export of Remdesivir till coronavirus situation improves | Business Standard News
The union government on Sunday suspended the export of Remdesivir injections and Remdesivir Active Pharmaceutical Ingredients (API) till the coronavirus situation improves in the country […] “The current situation has led to a sudden spike in demand for Remdesivir injection used in treatment of Covid patients […] In addition, the government has taken the steps to ensure easy access of hospital and patients to Remdesivir All domestic manufactures of Remdesivir have been advised to display on their website, details of their stock lists or distributors t […]
2
India bans export of Remdesivir drug, injection till Covid situation improves
“Export of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) prohibited till the COVID-19 situation in the countr […] This has led to a sudden spike in demand for Injection Remdesivir used in treatment of COVID patients. There is a potential of a further increase in demand for Remdesivir injection in the coming days,” the Centre said in a statement […] of Pharmaceuticals has been in contact with domestic manufacturers to ramp up the production of Remdesivir, it further stated. In its fresh order, it said that all domestic manufactures of Remdesivir advised to display on their website, details of their stockists/distributors to facilitate acces […]
10
No lockdown in MP, only ‘corona curfew’: Chouhan | Health
[…] We have received 4,000 injections of Remdesivir (the key anti-viral drug) and would be getting 5,000 more today […]
0
India Bans Export Of Anti-Viral Drug Remdesivir Amid Surge In Covid Cases
[…] In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients (API) till the pandemic situation in the country stabilises […] To ensure more people can get Remdesivir, the government said manufactures of Remdesivir have been asked to show on their website the details of their stockists and distributors […] of Pharmaceuticals has been in contact with the domestic manufacturers to ramp up the production of Remdesivir,” the government said. The National Clinical Management Protocol for COVID-19 lists Remdesivir as an investigational therapy, where informed and shared decision making is essential […]
14
Remdesivir injections and Favipiravir tablets vanish from UP’s Prayagraj medicine shops | Allahabad News
dlsnewsindia.com – Today
PRAYAGRAJ: The Remdesivir injection and Favipiravir tablets seem to have vanished from the city-based medicine market wit […] at Leader road dealing wholesale medicine market claimed that there was an acute shortage of Remdesivir injection and Favipiravir tablets […] UP Chemist & Druggist Federation admitted to TOI that there has been an acute shortage of Remdesivir injection and Favipiravir tablets in markets and we have been demanding from concerne […] “ I have made calls to my relatives to arrange Remdesivir injection after seeing its acute crisis in city” said Ashutosh who arrived Leader road medicin […]
0
NEWS HIGHLIGHTS FROM WESTERN REGION AT 5 pm. | Law-Order
[…] BOM2 MH-REMDESIVIR-CONTROL ROOMS Maha to set up control rooms for smooth supply of Remdesivir Mumbai: The Maharashtra government has decided to set up district-level control rooms to ensur […] government has decided to set up district-level control rooms to ensure smooth supply of Remdesivir injections and prevent hoarding and black-marketing of the drug, officials said on Sunday […]
0
Coronavirus update: Latest Covid-19 vaccine and world news
[…] India has banned the export of anti-viral drug remdesivir and its active pharmaceutical ingredients following a rise in coronavirus cases, a statement fro […] The ban would apply to Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) until the Covid-19 situation in the country improves, th […] ministry said, adding that this rise has led to a sudden spike in demand for the anti-viral drug remdesivir and its active pharmaceutical ingredients used in the treatment of coronavirus patients […]
13
Business & Financial News, U.S & International Breaking News | Reuters
[…] Carnival-loving, eloquent Soeder wants to be Germany’s first Bavarian chancellor 2h ago India bans Remdesivir exports as coronavirus rages on; rallies continue 2h ago Pacific island devotees of Prince Phili […]
7K
AAP slams BJP’s ‘free Remdesivir distribution’ in Surat; Guj CM says ‘not from govt stock’
Last Updated: 11th April, 2021 16:37 IST AAP Slams BJP’s ‘free Remdesivir Distribution’ In Surat; Guj CM Says ‘not From Govt Stock’ Slamming BJP’s Gujarat unit over Remdesivir injection hoarding, AAP said that the BJP had taken PM Modi’s message of  “converting disasters o […] Currently, Gujarat’s neighbouring state Maharashtra too is facing an acute Remdesivir shortage. READ | Maharashtra to set up control rooms for smooth supply of Remdesivir amid COVID crisis “About Surat, C R Paatil has arranged for 5,000 Remdesivir injections […]
3
FREE Coronavirus Awareness Training – Free E-Learning Course
[…] trials are looking at the potential use of two HIV drugs as well as another antiviral called Remdesivir that was developed to tackle haemorrhagic fevers including Ebola […]

This Remote Patient Monitoring Startup Just Landed A $70 Million Series C

Health Recovery Solutions in action

hen Covid-19 cases began to soar around Ann Arbor in April, the University of Michigan Hospital reached 100% capacity. Like most hospitals, University of Michigan Hospital was not ready for the pandemic surge, but they did have a leg up.

That same month they’d coincidentally implemented Health Recovery Solutions’ remote patient monitoring, a patented technology system that records patient vitals via Bluetooth and connects them with their clinicians through video or instant messaging. This enabled the resource-strapped hospital to care for over 400 patients remotely throughout 2020.

Today, HRS announced it closed a $70 million series C led by LLR Partners with participation from existing investor Edison Partners, bringing the Hoboken, New Jersey-based startup’s total funding to $86 million. The news comes on the heels of a year of massive growth, which saw their head count balloon 258% to 155 employees and revenue grow by 188% to $23.5 million.

“People are choosing the proven remote-monitoring solution right now,” says Jarrett Bauer, HRS’ Forbes 30 Under 30 cofounder and CEO. “That’s one of the reasons why we’re doing so well—people are looking for the company that’s best.”

Bauer, now 34, was inspired to start by HRS by his grandma. Battling a heart condition, Bauer’s grandma was admitted to the hospital three times, resulting in over $14,000 of medical bills. While pursuing his M.B.A. at Johns Hopkins in 2012, Bauer began constructing an at-home hospital alternative that would eventually become HRS. “We didn’t know where to start,” Bauer told Forbes in 2019 when the company raised its $10 million series B. “We just knew it was a problem, and the best companies solve problems.”

With Covid-19, telehealth doctor appointments have become just doctor appointments, increasing 154% from March to October of 2020, according to the Centers for Disease Control. Rather than cut into HRS’ margins, the telehealth boom has helped HRS soar. The healthcare company has deals with over 220 U.S. healthcare systems—74 of which signed on as clients of HRS during the pandemic—with over 20,000 nurses checking HRS logs every day.

“We consider Health Recovery Solutions the Cadillac model,” says Brandy Knudson, Michigan Medicine’s Telehealth Project Manager. “It fills a huge gap for us because we want to reduce readmissions and reduce unnecessary trips to the hospital.”

The company makes money by billing clinical institutions on subscription to integrate their solutions in treatment, coming at no additional cost to patients. HRS recognizes the varying levels of sickness and technological ability of patients, so the company’s products range from a pulse oximeter for the sickest, while near-recovered patients can manually enter symptoms on HRS’ smartphone app.

All of this patient data is stored in a cloud for clinicians, making it easier to recognize prognosis patterns and health trends. By implementing HRS, major healthcare systems like Penn Medicine have reduced 30-day readmission by over 50% for all heart failure patients, while FirstHealth of the Carolinas says the technology has saved patients more than $1.9 million since its implementation in 2016.

“Patients are looking to stay in their homes longer, get care in their homes longer, and there’s an increasing prevalence of chronic conditions,” says Sasank Aleti, a partner at Philadelphia-based private equity firm LLR Partners. “HRS met our criteria of taking costs out of the system, driving better outcomes and a better patient experience.”

For Bauer, the future of HRS lies in universalizing hospital-from-home treatment. With the $70 million round, the company plans to more than double head count in 2021 to 250 employees with the goal of being able to treat over a million patients by adding new healthcare providers and upping their disease module count (they currently treat 90 diseases). “Why aren’t we like Google? Why aren’t we like Apple?” asks Bauer. “We’re playing to win—to be that.”

I’m the Under 30 Editorial Community Lead at Forbes. Previously, I directed marketing at a mobile app startup. I’ve also worked at The New York Times and New York Observer. I attended the University of Pennsylvania where I studied English and creative writing. Follow me on Instagram and Twitter at @iamsternlicht.

Source: This Remote Patient Monitoring Startup Just Landed A $70 Million Series C

.

.

The coronavirus pandemic has overwhelmed hospitals, physicians and the medical community. That’s pushed telemedicine into the hands of providers and patients as the first response for primary care. Telemedicine isn’t new to the medical community, however it hasn’t been embraced due to insurance coverage, mindset and stigma. Here’s how it works and what it means for the future of health care. » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
.
More Contents:
Ro co-founder and Chief Product Officer Saman Rahmanian on VatorNews podcast
vator.tv – Today
[…] and Bambi Francisco interview Saman Rahmanian, co-founder and Chief Product Officer at Ro, a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation […]
N/A
H|T: The Healthtech Times – A Shopify for pharma
betakit.com – Today
[…] bottom of this page to ensure you don’t miss out on the most important healthtech news every week! Telehealth startup Dialogue to go public on Toronto Stock Exchange, targets $100 million IPO (BETAKIT) Telehealth startup Dialogue has officially filed to be public on the TSX amid an increasing trend of Canadian tec […]
0
Doing Business in Osceola County
[…] by News Break1d 177Share Texas Government|Posted by Austin Business Journal1d Birth control-focused telehealth startup expands beyond East Coast to Texas Though the Affordable Care Act, mandating no out-of-pocket fe […]
0
This Mental Health Startup Is Open 24/7 To Refill Your Medications
http://www.forbes.com – March 17
Minded, a telehealth startup that renews and delivers mental health medications, announced its launch today for patients in th […]
2
Canadian startup news of the week (3/14/21)
betakit.com – March 15
[…] Telehealth startup Dialogue to go public on Toronto Stock Exchange, targets $100 million IPO The startup reported it […]
1
TytoCare Is an AI Telehealth Startup Company Making Healthcare More Accessible Amid COVID-19
startupsavant.com – March 13
TytoCare, an AI remote healthcare startup company, wants to make remote healthcare more accessible, and the business has raised over $150 million in funding to help them do it.
N/A
Portland telehealth startup Bright.md hires new CEO from Opal – oregonlive.com
Fast-growing Portland telehealth startup Bright […]
2
HOT JOBS & COOL JOBS: CHIEF ENGINEER CYPRESS CA USA
[…] Los Angeles, CA, USA If you are a Director of Engineering with experience, please read on! We’re a telehealth startup based in LA transforming experience management for some of the biggest names in healthcare […]
0
Telehealth startup Dialogue to go public on Toronto Stock Exchange, targets $100 million IPO
betakit.com – March 9
Telehealth startup Dialogue has officially filed to be public on the Toronto Stock Exchange (TSX) amid the increasin […]
1
Top digital health exec’s advice to startups: Once you think you “know” you’ve lost the game
medcitynews.com – March 9
[…] in the digital health space—after working as a hospitalist, she served as an early advisor to telehealth startup Doctor on Demand, before joining Castlight Health and later, Livongo […]
N/A
HOT JOBS & COOL JOBS: CHIEF ENGINEER ANAHEIM CA USA
[…] Los Angeles, CA, USA If you are a Director of Engineering with experience, please read on! We’re a telehealth startup based in LA transforming experience management for some of the biggest names in healthcare […]
N/A
Erin Lee, Babylon Health, on leveraging AI to break geographic silos | by Jing Chai | The Pulse by Wharton Digital Health | Mar, 2021
medium.com – March 8
[…] Babylon is a London-based telehealth startup leveraging AI to provide quality and affordable primary care around the world […]
1
Rennova cancels deal to create telehealth company
[…] visits UnitedHealthcare’s 2 vital care tools won’t go away after pandemic, CIO says New York taps telehealth startup Ro to launch at-home COVID-19 vaccination program   © Copyright ASC COMMUNICATIONS 2021 […]
N/A
Looped Raised $7.7M, Axonius Pulled In $100M, and More NYC Tech News
[…] This telehealth startup sends customers medical kits to help them conduct various examinations at home […]
1
Mednow closes $37 million IPO as it’s set to list on TSXV
betakit.com – March 5
[…] Montreal telehealth startup Dialogue reportedly also plans to go public on the TSX later this year […]
2
COVID-19 Telehealth Startup Checklist
http://www.mgma.com – March 5
This tool helps you assess needs for telehealth during the COVID-19 emergency, as well as considerations for choosing a long-term telehealth vendor after the crisis.
N/A
News Briefs Archives
nocamels.com – March 5
[…] ” Read More Israeli Telehealth Startup Tyto Care Raises $50M, Doubles Its Valuation Israeli telehealth firm Tyto Care has raised $5 […]
3
Telehealth startup TytoCare raises $50M in oversubscribed Series D round extension
siliconangle.com – March 5
Artificial intelligence-powered telehealth startup TytoCare Ltd […]
1
Telehealth startup TytoCare raises $50M in oversubscribed Series D round
siliconangle.com – March 5
Artificial intelligence-powered telehealth startup TytoCare Ltd […]
0
Telehealth startup TytoCare raises $50 million as COVID pushes doctors online | The Times of Israel
TytoCare, a telehealth startup that has developed an artificial intelligence-based device that enables clinicians to perfor […]
1
Tyto Care Grabs Another $50M to Expand Remote Medical Exam Capabilities
[…] Due to this shift, New York City-based telehealth startup Tyto Care more than doubled the size of its revenue last year, and now, it’s receiving a fres […]
1
Israeli Telehealth Startup Tyto Care Raises $50M, Doubles Its Valuation
nocamels.com – March 4
Israeli telehealth firm Tyto Care has raised $155 million to date.
1
Introducing FTMO Spring Batch of 2021
[…] startups have been chosen for this year’s program: Neurolytic Healthcare An Oxford based precision telehealth startup using genomics and digital biomarkers to remotely personalize treatment for migraine […]
0
UnitedHealthcare’s 2 vital care tools won’t go away after pandemic, CIO says
[…] More articles on telehealth:  New York taps telehealth startup Ro to launch at-home COVID-19 vaccination program HHS stresses commitment to telemedicine frau […]
N/A
260+ telehealth companies to know | 2020
[…] Remedy is a telehealth startup that offers a standalone benefit for employers, groups and payroll companies to deliver primar […]
N/A
New York taps telehealth startup Ro to launch at-home COVID-19 vaccination program 
New York taps telehealth startup Ro to launch at-home COVID-19 vaccination program  The New York State Department of Health i […]
N/A
A telehealth startup gained 6x as many clients in the COVID-19 crisis
Spanish startup HumanITCare went from 3 clients to 20 during the coronavirus health crisis and expects to end 2021 with a turnover of $1.2 million.
1
Los Angeles Telehealth Startup Expands Remote Patient Monitoring with CDFI Assistance
cdfistory.ofn.org – February 26
Client: Kelly Nguyen, owner of DrKumo Client location: Los Angeles, CA CDFI: PACE CDFI service area: California CDFI services provided: Financing and technical assistance Learn how PACE…
1
Software Customer Experience Team Member at EUC Services Pty Ltd
startup.jobs – February 24
Customer Support for Telehealth Startup! Description Software is changing the face of the skincare industry in Australia […]
N/A
20Fathoms Announces Virtual HealthSpark Digital and Telehealth Startup Accelerator (Deadline) –
cronicle.press – February 23
[…] experience and can network with leaders in their space who know what it is to build a digital or telehealth startup on the ground […]
N/A
Improving Product And Engineering Team Relationships In 2021
http://www.forbes.com – February 23
[…] Co-founder and CTO at telehealth startup MEDvidi […]
1
Pure Tinnitus Offers Remote Group Coaching Sessions
California-based telehealth startup Pure Tinnitus announced that it has developed Pure Tinnitus Group Coaching as a way to provid […]
N/A
3 of the Latest Companies to Go Public Via SPACs
investorplace.com – February 17
[…] com Telehealth startup Hims & Hers Health is connecting subscribers to licensed health care professionals and offer […]
N/A
What I Wish I Knew: One piece of advice for Founders
http://www.linkedin.com – February 13
[…] CEO and co-founder Silvia Pfeiffer of the telehealth startup Coviu helps patients avoid the travel and time required to attend a GP clinic, as well as openin […]
N/A
Optum-Backed Telehealth Startup For Eating Disorder Treatment Raises $13 Million
http://www.forbes.com – February 11
Equip is attracting insurance companies by offering a less-expensive alternative to residential treatment.
3
Astrata, UPMC’s newest spinoff, puts NLP to work for quality improvement
[…] coming year, joins a wide array of other spinoffs incubated at UPMC over recent years, including telehealth startup Abridge, LTPAC-focused Curavi (which merged this past year with two other companies to form Arko […]
1
Transgender-Focused Telehealth Startups : telehealth startup
[…] Nedelcheva — February 4, 2021 — Marketing References: folxhealth & fastcompany Folx Health is a new telehealth startup, built for the transgender community […] The telehealth startup will operate on a subscription basis, with patients paying a fee starting at $59 USD per month […] The telehealth startup is planning to expand into “treatment for erectile dysfunction, sexually transmitted infection […]
N/A
Europe’s top 30 young VCs primed to lead the top investment funds
sifted.eu – February 4
[…] She’s a self-proclaimed consumer aficionado, having developed the go-to-market strategy for a telehealth startup […]
N/A
Healthcare, Hardware and Energy January Roundup
mailchi.mp – February 3
[…] Accolade Accolade, a health benefits platform, is buying telehealth startup 2nd […]
N/A
Australian Telehealth Startup Wins giant US Wellness Health $231.8 million agreement
healthreporter.com.au – February 2
The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S.manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once…
N/A
Digital + Telehealth Startup? Apply To Traverse City Accelerator
mynorth.com – February 2
Have a digital and telehealth startup but need that extra push to really take off? 20 Fathoms, a Traverse City-based nonprofit providin […]
1
Not Just An Emergency Fix: Telemedicine Is Poised For Growth In The GCC
[…] Related: Dubai-Based Telehealth Startup InstaPract Helps Patients Consult Doctors From A Distance During COVID-19 Pandemic
N/A
January 2021 Deals & Investments
http://www.baybrazil.org – February 2
[…] Jan 14 Brazil’s ViBe Saúde, a B2C telehealth startup in Brazil, announced it has raised a US$10 million Series A funding round led by a group of Swedish […]
N/A
Tyto Care telehealth platform adds a pulse oximeter to expand at-home health monitoring
[…] Other companies to recently launch new telehealth capabilities include Hims & Hers, a telehealth startup that went public in a $1 […]
N/A
Issue No. 115: The Rise of Virtual Races
insider.fitt.co – January 26
[…]   Telehealth startup hims went public in a SPAC deal with Oaktree Acquisition Corp […]
N/A
Female-Founded Telehealth Startup Calibrate Announces $22.5 Million Series A on 27 January
http://www.iweller.com – January 26
Calibrate, a female-founded telehealth startup that aims to provide patients with a metabolic reset, announced Tuesday that it has raised a $22 […] Calibrate When Calibrate—the female-founded telehealth startup trying to disrupt the $70 billion weight loss industry—came out of stealth mode in June, it wa […]
0
Female-Founded Telehealth Startup Calibrate Announces $22.5 Million Series A
http://www.forbes.com – January 26
When Calibrate—the female-founded telehealth startup trying to disrupt the $70 billion weight loss industry—came out of stealth mode in June, it wa […]
N/A
Bene Studio –
medium.com – January 26
[…] Schedule: Startup pitches and the Telehealth Startup Award 8:00–9:00 (PDT) / 16:00–17:00 (GMT+1) 4 growth stage health startups pitch their product an […] Who will win the Telehealth Startup Award in September? Panel Discussion: How does Telehealth improve Health Systems? 9:30–10:30 (PDT […]
N/A
LIST OF FASTEST GROWING FRANCHISES IN AMERICA :: Stock market news, Stock spinoff and breaking finance news.
[…] GoTelecare Franchise fee: $100,000 (in liquid assets) Initial investment: $60,000 GoTelecare is a telehealth startup that is currently building a franchise business model […]
1
When SPACs Attack! A New Force Is Invading Wall Street.
http://www.wsj.com – January 23
[…] Telehealth startup Hims & Hers Health Inc […]
12
H|T: The Healthtech Times – Blunder drug
betakit.com – January 22
[…] Health benefits platform Accolade is buying telehealth startup 2nd […]
N/A
Hims, The Telehealth Start-up, Saw Its Shares Slide In Its Business Debut – And That’s Great For Its CEO – TechCrunch
Hims & Hers, a San Francisco-based telehealth startup that sells sexual wellness and other health products and services to millennials, began tradin […]
0
Telehealth startup Hims fell in its public trading debut – and that’s fine with its CEO
tech.wmlcloud.com – January 22
Telehealth startup Hims fell in its public trading debut – and that’s fine with its CEO Source : techcrunch.com<br />…
0
Forging Trust In AI, Sustaining The Virtual Care Boom And Other CES Takeaways – Food, Drugs, Healthcare, Life Sciences – United States
http://www.mondaq.com – January 21
[…] of specialization within telehealth that people will really gravitate towards,” Varsha Rao, CEO of telehealth startup Nurx, said Tuesday […]
1
StartUp Health –
medium.com – January 19
[…] <source> Calibrate, a New York, NY-based female-founded telehealth startup that aims to provide patients with a metabolic reset, raised $22 […]
1
Portland telehealth startup Conversa raises $8M
http://www.geekwire.com – January 19
[…] -based telehealth startup, has raised another $8 million as part of an expanded Series B round […]
N/A
TeeRoy’s 2 Cents Rumor Report 1/19/21 | 100.9 The Beat
wjbt.iheart.com – January 19
[…] already has stake in Wingstop and Checkers recently put a million dollars into the Florida-based Telehealth startup Jetdoc […]
1
Forging trust in AI, sustaining the virtual care boom and other CES takeaways
[…] of specialization within telehealth that people will really gravitate towards,” Varsha Rao, CEO of telehealth startup Nurx, said Tuesday […]
N/A
Rick Ross Ensures Health Is Wealth With $1M Investment In JetDoc Startup
hiphopdx.com – January 17
[…] According to Forbes, the 44-year-old Ross is making a seven-figure investment into Florida-based telehealth startup Jetdoc […]

Mammograms Pick Up Swelling Related To The Covid-19 Vaccine Study Says

When she found a lump in her left breast during a routine self-check, Boston primary care physician Dr. Devon Quasha knew exactly what to do. She immediately scheduled a diagnostic mammogram and ultrasound at Massachusetts General Hospital for early January.

Quasha didn’t notice much of a reaction to the vaccine at first, but a couple of days before her appointment her left arm began to hurt.
Tender, swollen lumps developed under her left armpit, along with a large swelling above her collarbone — all areas where there are lymph nodes, the body’s filters for germs.
“You have lymph nodes above and below your collarbone,” Quasha said. “You don’t want to feel those. It was scary when I felt it.”
Lymph nodes contain immune cells that help fight invaders. That’s why it made sense to Quasha that the nodes were reacting to the vaccine, building antibodies as they were designed to do. But she couldn’t be sure.
The swelling was only on the left side where she had gotten the shot — the same side as the worrisome lump. Was it a reaction to the vaccine or another sign of breast cancer?

‘It was like a wildfire’

After the ultrasound, Quasha’s radiologist was concerned. She told Quasha she considered the lump she had felt in her breast to be of little significance, but the lymph nodes that showed up as white blobs on her mammogram were another matter. In non-pandemic times, that finding would set off alarm bells, requiring the need for further investigation, even an immediate biopsy.
Yet Quasha had just had the vaccine. After talking it over with her, Quasha said her doctor decided not to do a biopsy at that time. Instead she told Quasha to come back for a follow-up ultrasound in six weeks.

“I cannot tell you how many women are showing nodes on mammograms and people thought it was going to be not that common,” said Lehman, who is also a professor of radiology at Harvard Medical School.
Tales of unnecessary biopsies spurred the patient care committee of the Society of Breast Imaging (SBI) to put out an advisory in January: Ask your patients about their Covid-19 status, and record the date and which arm received the vaccine. Consider that before automatically scheduling a biopsy.
“We wanted to advocate that women don’t always need to have a biopsy,” said Dr. Lars Grimm, associate professor of radiology at Duke University School of Medicine and one of the authors of the SBI advisory. “Because oftentimes the default if you see swollen lymph nodes in a patient would actually be to recommend doing a biopsy.”
Mass General’s Lehman agreed. “When you hear hoofbeats, don’t think zebra,” she said. “If a woman had a vaccine in the arm on the same side, and the lymph nodes are swollen, this is a normal biological response. It’s totally expected. It just doesn’t make sense to start imaging.”
That does not mean that women who wish to be sure about their cancer status cannot have a biopsy, Grimm stressed. “You actually have some women who want to biopsy,” he said. “You might tell them, ‘Hey, I think this is due to your Covid vaccine, and I’m sure that it’s going to resolve in a few weeks on its own and you’re going to be fine.’ But that patient tells you, ‘I’m not going to be comfortable waiting, I want to know now.’ “

Focus on screening to save lives

For Quasha, the knowledge that many women were experiencing the same type of reaction to the vaccine was a welcome relief from worry. After a discussion with her doctor, she said she no longer needs the follow-up screening. “I was very reassured,” Quasha said. “The point here is that there are a number of side effects from the vaccine which are not dangerous but can sometimes increase patient anxiety.”
Instead of bringing women back in for an unnecessary ultrasound, radiology centers should be focused on scheduling women who have missed or are overdue on their mammogram, Lehman said.
“We need to take care of the large percentage of women who didn’t get screened because of the shutdowns during Covid,” she said. “At Mass General alone, we failed to screen 15,000 women because of Covid, and we’re still trying to get them back in.
“This isn’t where I need to start doing axillary ultrasounds, because someone had a vaccine and the node swelled. It’s just not being practical or pragmatic or putting our patient’s needs first,” she said. It’s not just breast cancer, Lehman stressed. Lymph nodes in other parts of the body are also reacting to the Covid-19 vaccines, causing people with other forms of cancer to undergo unnecessary procedures.
“There have been some false scares and some unnecessary biopsies because people didn’t think to ask, and they assume that the node was the cancer coming back,” she said.

What to do?

To avoid unnecessary worry, SBI recommends women schedule any routine, annual breast screening before getting the Covid-19 vaccine. If a woman has already had the vaccine, or is soon scheduled to do so, the society suggests waiting at least four to six weeks after the second dose before scheduling your appointment.
At Mass General, Lehman and her team have gone a step further. They are screening all women regardless of vaccine status, but telling those with no history of cancer that any swelling in the lymph nodes that might be connected to a Covid-19 vaccine is benign — meaning not cancerous.
“This follows the American College of Radiology recommendations that if you have a known inflammatory cause you can say it’s benign,” said Lehman, who recently published a paper on the hospital’s procedures.
“If their concern is a swelling or tenderness after the vaccine in their armpit, we suggest that they wait four to six weeks, talk to their doctor, and if it persists, then we have them come in to do an evaluation of it,” she said.
Whatever you do, experts stress, don’t skip getting your breast cancer screening when it is recommended. A study published Tuesday in the journal Radiology that followed over half a million women made the point clearly: Women who skip even one scheduled mammography screening before they are diagnosed with breast cancer have a significantly higher risk of dying. In fact, the risk of having a fatal breast cancer within 10 years of diagnosis was 50% lower for women who had regular breast screenings, the study said.

By: 

Source: Mammograms pick up swelling related to the Covid-19 vaccine, study says – CNN

.

.

More Contents:

Health Care Costs & Quality
[…] National Cancer Institute and the American College of Obstetrics and Gynecology recommend regular mammograms for woman and regular MR imaging for women in specified high-risk categories […]
N/A
Ayurvedic Breast Cancer Treatment | Cancer Treatment in Delhi
topdoctorsindelhi.com – Today
[…] Having dense tissues in the breast: Dense breast tissue creates difficulty in reading mammograms while increasing the risk of breast cancer […]
0
Some women finding lumps after covid shot, but experts say it’s likely not breast cancer
[…] “As radiologists, we see this on mammograms after people have had the flu vaccine, the shingles vaccine, the pneumococcal vaccine so this isn’t […]
354
Underarm Lump After COVID Shot Is Likely Lymph Swelling, Not Breast Cancer, Experts Say
[…] When seen on mammograms, these vaccine-swollen nodes can be mistaken for those enlarged because of cancer […] ” During the pandemic, screening mammograms and breast cancer diagnoses have declined sharply in many health care institutions, Lehman said […]
0
RV Brings Mammogram Screenings To Women In Louisville Area
spectrumnews1.com – Today
[…]   What You Need To Know An RV in the Louisville area is performing mammograms of women 40 and up UofL’s Brown Cancer Center and the Kentucky Cancer Program partner to operat […] Cancer Center and the Kentucky Cancer Program partner to operate the screening center each year The mammograms are free for those who don’t have insurance and are income qualified Funds are available to cove […] Insurance will pay for it, and the reason for that is mammograms can detect a breast cancer long before it can be felt, and so the sooner that breast cancer i […]
0
The Breast Cancer Site | Click to Fund Breast Cancer Research
theliteracysite.greatergood.com – March 6
Critical Help: Mammograms, Treatment, & Support These needs are key to surviving breast cancer. Mammograms help show the existence and extent of the cancer […] Mammograms, treatment, & support […]
N/A
Radiologist accused of misreading 18 patient mammograms hands over medical license
Radiologist accused of misreading 18 patient mammograms hands over medical license Matt O’Connor | March 05, 2021 | Practice Management The owner and sol […] medical license recently after the state board of medicine charged him with misreading a number of mammograms […] labeled Bigg as “incompetent to practice medicine and surgery” due to his pattern of misreading mammograms […]
0
Covid vaccine-induced swelling can lead to false cancer diagnosis, doctors warn — RT USA News
http://www.rt.com – March 6
[…] volumes” of chest computed tomography (CT) scans, positron emission tomography (PET) scans and mammograms showing swollen lymph nodes as vaccination drives continue […]
3
A mixed‐methods study to evaluate the acceptability of information leaflets for breast cancer screening – Fernández‐Feito – – Journal of Clinical Nursing
onlinelibrary.wiley.com – March 6
[…] These leaflets include relevant information about mammograms to aid with decision making […] The leaflet included information about breast cancer, mammograms, benefits/risks of screening, and the breast cancer mortality and survival rates in relation t […] The leaflet was viewed as a decision‐aid, although further information was requested on mammograms, the need for complementary tests and the risks and symptoms of breast cancer […]
N/A
Screening Mammography & COVID-19 Vaccine: What to Know
iuhealth.org – March 6
Screening mammograms and COVID-19 vaccines are both very important for your health […] Regular screening mammograms ensure that breast cancer can be detected as early as possible […]
1
Mammogram – Lancaster General Health | Penn Medicine
[…] cancer Women ages 40 to 44 should have the choice to start annual breast cancer screening with mammograms if they wish to do so […] Women age 45 to 54 should get mammograms every year. Women age 55 or older should switch to mammograms every two years, or have the choice to continue yearly screening […] Each location follows the same gold standard protocols, and all mammograms are sent electronically to the Suzanne H […]
1
Managed Care – a Path to the Future
[…] example, HEDIS scores reflect compliance with prevention measures, such as scheduling flu shots, mammograms and annual physicals—all important elements of population health […]
2
Swelling after COVID-19 shots may cause cancer false alarms
http://www.msn.com – March 6
[…] should “prepare to see large volumes” of imaging exams — including chest CTs, PET scans and mammograms — that show swollen lymph nodes, according to similar recommendations in the Journal of th […]
N/A
COVID-19 Vaccine Shows New Side Effect as it May Result in False Positive on Mammograms
[…] What causes the confusion during mammograms is that breast cancer causes lymph nodes under the armpit to swell too […] Due to the similarities, some patients got false-positive results in their mammograms […] Texas, told KHOU in an interview that they had witnessed at least 10 false-positive results in mammograms this week alone […]
1
Pétition · Covered Preventative Mammograms for Women starting at age 30 by All Insurance Companies ·
[…] So I am asking to get the age of preventative and diagnostic Mammograms to be covered by insurance at the age of 30 […]
3
AI and machine learning to help global battle with cancer
thedailyguardian.com – March 6
[…] There are an estimated 2,700 mammograms installed in India, which represents less than 5% of that in the United States […]
1
What are Discount Dental Plans? – JustPaste.it
justpaste.it – March 6
[…] administrations, for example, research facility tests, imaging examines (MRIs, CAT checks, mammograms), non-intrusive treatment, diabetic supplies, amplifiers, and psychological well-bein […]
0
Wendy Petrie’s brush with skin cancer prompts warning for others
[…] distracted and anxious about a pandemic, but it’s also important not to forget about things like mammograms, like skin checks, like every other normal health check you would worry about […]
1
Time awake and hours slept significantly impact less experienced radiologists’ performance
[…] who were awake for less than two hours demonstrated much lower sensitivity at spotting lesions on mammograms compared to those awake 8-10 hours […] Bottom line: They did not for experienced radiologists who read more than 2,000 mammograms per year […]
N/A
Women recently injected with experimental covid vaccines are showing symptoms of BREAST CANCER : The Government | Government-Canada.com – Breaking news on governance on Canada & video.
[…] of dealing with the cause of this problem (vaccines), the doctors are now telling women not to get mammograms after vaccination […] The doctors now advise all women patients to reschedule their yearly mammograms, either before the first dose or four weeks after the second dose […]
0
Safety Steps | Sutter Health
[…] Routine Care Schedule recommended annual screenings like mammograms, colonoscopies and Pap smears […]
N/A
How is radiography training in Europe bearing up in the pandemic?
[…] 2 million mammograms were missed due to the suspension of breast cancer screening, and these have to be rescheduled, […]
N/A
Healthy Body, Healthy Pocketbook | William Larson
[…] by your doctor, take advantage of free or low-cost diabetes and heart disease screenings, mammograms, and vaccinations […]
N/A
Healthy Body, Healthy Pocketbook | Taylor Wealth Management Group
[…] by your doctor, take advantage of free or low-cost diabetes and heart disease screenings, mammograms, and vaccinations […]
N/A
Healthy Body, Healthy Pocketbook | Jackson Square Financial
[…] by your doctor, take advantage of free or low-cost diabetes and heart disease screenings, mammograms, and vaccinations […]
N/A
Healthy Body, Healthy Pocketbook
[…] by your doctor, take advantage of free or low-cost diabetes and heart disease screenings, mammograms, and vaccinations […]
N/A
Weekly Sales Report: Cute Winter Basics + Fun Pieces For Spring & Summer
themomedit.com – March 6
[…] Shana this week discussing various medical appointments, my tooth that broke while eating a bagel, mammograms, LED light therapy wrinkle reducing devices, and facial exercises to decrease the effects o […]
1
Swelling From COVID-19 Vaccines Confused for Cancer Scare
http://www.ny1.com – March 6
[…] is now following recommendations from the Society of Breast Imaging, which issued guidelines for mammograms after receiving a COVID-19 vaccination […]
1
Indiana doctor reflects on a year of COVID-19: ‘The hardest part is that we don’t know where the end is’ – Chicago Tribune
[…] ” What else should people know? Early on, the pandemic caused countless patients to miss mammograms, pap smears, colonoscopies, other cancer screenings and annual doctor visits […]

Taking Breaks At Work In 2021: The Secret To Productivity and Well-Being When You Work From Home

We’ve all sat through weary-eyed, leg-cramping power sessions at our desk, chasing a deadline, or busy dealing with endless tasks, emails, and meetings (now zoom meetings) back to back. 

If you are one of the millions moving to working remotely in 2021, you are probably working longer hours, putting in more continual desk time, and without the daily commute, more sedentary than ever.

In a recent report released from the National Bureau of Economic Research, researchers discovered that workers are working close to an hour more per day during lockdowns than they were before the pandemic. 

So, how do we navigate the new normal and restore our productivity, focus, and well-being? 

The secret is to take regular breaks at work

“Almost everything will work again if you unplug it for a few minutes…including you.”
― Anne Lamott

If you listen to the experts, breaks are essentially little “interventions” that help us gracefully and productively manage the daily grind with rationale and perspective intact.

This complete guide covers all the nitty-gritty about taking breaks at work.

You will learn the importance of taking breaks, how to take effective breaks, what to do on your daily breaks to truly relax and boost your productivity, and a step-by-step guide on how to design a system so that you can easily make breaks a regular part of your routine and stick to it.

Sounds good?Let’s dive in.

Yes, it’s tempting to just want to “power through” one more hour of work. You don’t want to take breaks because you think you can get more done. But did you?

One day you started realizing that your neck, wrist, and back are hurting, despite being an otherwise health-conscious, active lifestyle advocate.

Whether you’re an employee or project stakeholder, hours spent sitting at a desk and staring at a screen puts a strain on your productivity and health.

Take a look.

Our Bodies Suffer

There is a lot of pressure to sit in the office – it’s how you get your work done. 

Now that you are probably spending more days working at home, where you don’t need to get up and walk around to talk to people. You are not walking to meetings, you don’t even need to commute. 

You are more exposed to the danger of sitting too much.

Researchers have linked sitting for prolonged periods of time to a significantly higher risk of heart disease, diabetes, obesity, cancer, and depression, as well as muscle and joint problems. 

Toni Yancey, a professor of health services at UCLA’s Fielding School of Public Health, describes the process: “Sitting shuts down electrical activity in the legs. It makes the body less sensitive to insulin, causes calorie-burning to plummet, and slows the breakdown of dangerous blood fats, lowering ‘good’ HDL cholesterol.”

What’s noteworthy is that:

A recent science advisory from the American Heart Association has shown that going to the gym, running, or your favorite fitness class, doesn’t cancel out the negative impact of time spent being sedentary.

Radical as it might sound, you can’t undo sitting.

While working out and fitness are important if your goal is to maintain or get in the best shape of your life, it cannot reverse the harmful effects of sitting for the rest of the day and moving very little within your office or home.

So, what’s the solution?

To take regular breaks to get up and move.

Our Brains Depleted

Despite all the physical damage, what happens to your brain when you don’t take breaks: Your productivity goes downhill…before you notice.

Brain scientists are very aware of the fact that prolonged work is depleting. The “fading” that we experience creates declines in mood and performance.

“We don’t know exactly what in the brain gets depleted, but when you do a cognitively demanding task, it operates as though there’s a ‘mental fuel’ that gets burned up.”
– William Helton, PhD, a professor of human factors and applied cognition at George Mason University

Recent studies show that those who give in to some kind of break once an hour perform better than those who just keep at it without a break.

The Power of Taking Breaks

Many people experience “productivity breakthroughs” after going against their instincts to meet a deadline by taking a pause. We emerge refreshed and more resilient after getting up for both brain and movement breaks.

So, how do breaks help us? 

Here’s a quick look at the magic taking breaks does to our brain:

  • Improved focus.
  • Boosted creativity and problem-solving abilities
  • Better information retention
  • Improved productivity
  • Prevents decision fatigue
  • Reevaluate goals and seeing the bigger picture
  • Better stress management

Besides the juicy benefits that breaks have on our brains, now what if you can double the benefits? 

It’s simple – add movement to your breaks.

For those who get the least amount of physical activity, replacing a half hour of sitting time with physical activity was associated with up to a nearly 50% reduction in mortality, according to a new study from the American Cancer Society.

Breaks are a great opportunity to incorporate movement into our workdays to combat the setbacks of a sedentary lifestyle. 

Take a look at the most important benefits of movement breaks:

  • Improve energy levels
  • Boost mood and relieve stress
  • Strengthen weakened muscles and bones
  • Reduces the risk of developing type 2 diabetes and cardiovascular disease
  • Reduces the risk of injury
  • Boost memory and focus

It’s pretty clear that taking breaks is a powerful tool that can make us better at what we do, feel physically better, and happier. 

High-performing people understand the power of taking breaks and know how to take advantage of effective breaks to become more productive while keeping their health in check.

So, how do you harness the power of taking breaks, so that you come back fully recharged both physically and mentally?

Continue reading to find out the strategy that actually works.

The Secret to Taking Effective Breaks at Work 

Although taking breaks at work might seem even harder when we are working from home and being “accessible” every waking minute, understanding how the brain works and taking the initiative to establish boundaries for effective breaks has quickly become the secret weapon to avoid burnout, improved productivity and personal well-being.

“Breaks are crucial,” says Cal Newport, author of Deep Work: Rules for Focused Success in a Distracted World. “If you’re working day after day and not letting up, you will burn out.”

Understanding the Productivity Cycle 

Our focus, energy, and motivation moves in “waves”. 

Those cycles are known as biological rhythms.

Productivity cycle refers to working for evenly spaced periods of time, and taking breaks at that exact rhythm.

Understanding your productivity cycle can help you take more effective breaks at work. 

“Working for 75 to 90 minutes takes advantage of the brain’s two modes: learning or focusing and consolidation,” says MIT Sloan Senior Lecturer Bob Pozen

According to Pozen’s findings, taking a 15-minute break following a productivity chunk allows our brains to better consolidate and retain information. Pozen’s findings echo the findings of research done by Tony Schwartz, the author of The Power of Full Engagement, showing that humans naturally move from full focus to fatigue every 90 minutes

How often should I take a break? And for how long?

There are many studies that have looked at optimal break schedules. Here are some of the most popular, science-supported methods which you could integrate into a workday:

  • Once Every Hour

Taking a 5 to 15 minutes break at the top of every hour like clockwork can get you ahead of the 75-minute fatigue curve. Plus, a top-of-the-hour break is easy to remember and execute.

  • Every 75 to 90 minutes

Following the brain’s “full-focus-to-fatigue” cycle, you can ride productivity waves all the way to the end before refreshing with a break for 5 to 15 minutes.

  • Pomodoro Technique

One of the most common ways to implement a schedule with breaks. Start with a to-do list and timer. After setting your timer for 25 minutes, focus on one task at a time until the timer buzzes. You will mark what you’ve completed before taking a non-negotiable 5-minute break. Enjoy a 30-minute break for every four pomodoros.

  • The 52:17 Method

Work in increments of 52 minutes before 17-minute breaks.

As you can see, all of these techniques essentially follow the same pattern of riding productivity peaks, followed by small breaks – typically 5 to 15 minutes. 

In doing this, we can build up new productivity cycles every 60 to 90 minutes without succumbing to the fatigue that naturally comes without breaks. 

However, how often you should take a break depends on the nature of your work and how your brain functions. Everyone is different. The key is to experiment and find your own rhythm.

Take breaks The Right Way

The Don’ts

Research shows that taking the wrong type of breaks could actually increase fatigue and steal your productivity, such as mindless snacking, online shopping, and mindlessly scrolling on social media. 

It’s also tempting to do some work during your breaks, such as checking your email or the message from your manager. It’s a no-no.

If these are the only breaks you are taking, keep reading to find out how to take breaks the right way.

The Do’s

To reap the maximum benefits of a break, you need to give your brain a chance to relax and your body a chance to recharge. 

The best practice is to incorporate activities into your breaks that bring you joy and positive vibes. 

For example, a short breathing exercise during your break can help lower blood pressure and relieve stress.‍

9 break ideas that boost your health and productivity

  • Simple stretches and mobilization exercises to relax and keep your body functioning, ease stiffness from sitting too long, and prevent injuries.
  •  (Home) office-friendly exercises to wake your sleeping muscles up, boost your energy level, and help you gain focus. Studies have shown that a moderate level of cardio activity can boost creativity and productivity for up to two hours.
  • A short walk outside. Despite the physical benefits, being physically detached from work, and getting some fresh air in your lungs improves your mood and lowers stress.Breathing/meditative exercise helps your body relax and is one of the most powerful ways to relax your brain and regulating your stress response.
  • Nap. If you are working from home, or work at a progressive company that affords you the luxury of taking a nap in the office. Take advantage of that. In several studies, a nap of as short as 10 minutes can improve your cognitive function and decrease sleepiness and fatigue. Having that afternoon slump? Nap it off. Be aware that naps that exceed 20 minutes might leave you feeling groggy and disoriented. It is best to limit your naps to 10 to 20 minutes.
  • Exercise your eyes to prevent eye strain, you can try the 20-20-20 rule.Healthy snacking. Replenish your brain with the right fuel. Here’s a look at some of the best snacks to eat at your desk
  • Talk to someone. Chat with a colleague or a friend (who is also on a break), grab a coffee down the street, take your dog on a walk, call your mom, or play with your kids if you are a parent working from home.
  • Laugh. Yes, go ahead and watch some funny videos of cats. According to a recent study, laugh breaks can improve your performance.

While it can be fun to work some creative activities into breaks, the goal remains the same if you want to maximize cognitive and physical boosts: 

1. Take your mind off work to give your brain a chance to truly relax;

2. Get up from your chair and move around to combat the negative effects of a sedentary lifestyle.

The step-by-step guide to make breaks a regular part of your workday

If you’ve read this far, you probably have a pretty good idea of why you need to take breaks, what to do on your breaks and have a strong intention to do so. 

Now you’re thinking, “but how do I implement it to my workday and make it a habit?”

It is surprisingly hard for most people to make the change to integrate breaks into the day, even when it’s something that they intend to achieve.

The problem is that most people fail to follow the instructions that they give themselves.

Let’s be honest, it’s way easier to sit on your chair and mindlessly scroll through your phone, OR, you could be so deep in your work that you don’t have extra mental energy to come up with stuff to do or even think about taking a break.

This is when you need a system to, sort of, automate that part of your day. It’s like having your coach showing up at your door every day at the same time to keep you accountable.

So, how do you design a system that helps you achieve this goal?

The perfect behavior-modification technique for this case is what psychologists call implementation intentions. It is a self-regulatory strategy that has been found to be particularly effective when it comes to situations where there may be immediate costs but significant long-term benefits, such as taking breaks at work. 

An implementation intention supports our goal intention by setting out in advance when/where and how I will achieve this goal.

Here’s how :

Step 1: Specify your goal. For example, “I will take a break every hour at work”.

Step 2: Schedule them in your calendar (the When). Alternatively, if you prefer to work in “sprints”, set a timer on your phone or computer. You can set a timer for 30-minutes, go with the 52:17 method, or whichever time is optimal for you.

Step 3: Plan out your break activities ahead to avoid needing to “decide” what to do when it’s break time, such as “Go for a 5-minute walk at 3 pm” (the How)

Step 4: Follow the cues you have outlined in your plan

As a result, your goal will be performed automatically and efficiently, without conscious effort. 

What we love the most about this technique is that it frees our cognitive resources for other brain-heavy tasks like study & work, since we don’t need to think about when to take a break and what to do for that break. It’s already planned!

Once you take the first step of planning it out, the automated system that you designed helps to remove the hesitation and deliberation when you want to take a break. It’s like putting your breaks on auto-pilot.

And…if you don’t want to go through the hassle of manually scheduling breaks into your workday, or waste your mental energy on coming up with what to do for your breaks, there are tools that are designed to make your life easier.

Follow along.

“Are there any tools that can help me take breaks?”

We are glad that you asked. Yes, there are.

At StretchMinder, we are obsessed with great tools that make life easier. After all, that’s what we believe what technology should be – making people’s lives easier.

Here are 7 hand-picked tools that help you take breaks:

  • StretchMinder – A unique blend of break reminder and 7-minute workout. From putting your breaks on auto-pilot with pre-scheduled breaks to providing guided activity routines including Movement, Breathing & Walking exercises, the app takes care of it all with just a few clicks. It is perfect for those who want the easiest way to build a habit of taking breaks and moving more throughout the day. 
  • Focus To-Do – A app that brings Pomodoro Technique and To-Do List into one place, you can capture and organize tasks into your to-do lists, start focus timer and focus on work & study, set reminders for important tasks and errands, check the time spent at work.
  • Focus Booster – A simple and lightweight timer that automatically records each session. The app features a Pomodoro timer, a mini timer, customizable session lengths, report exports, and manual time entry. 
  • Flow Time – A Chrome Extension to boost your productivity. It works as a Pomodoro-like timer & website blocker that boosts your productivity by making your mind go into the state of flow faster.
  • Google – If you want to keep things simple, just type “set a timer for X minutes” into Google and set your timer.
  • Your calendar – Schedule your break slots and set reminders on your calendar to repeat every day.
  • Your phone – Set a timer with the native timer tool and repeat every day diligently.

Source: https://www.stretchminder.com

.

Tanya Dalton

How taking breaks at work increases your productivity We try to work more efficiently and push ourselves at work, leaving less and less time for breaks and space to re-energize. Most people feel they never have enough time to take a quick break, or aren’t allowed to, but break times will boost your productivity and overall happiness. Increase productivity with these break ideas for work or home that are easy to implement. FREE Download: https://inkwellpress.com/breaks WATCH MORE: → 5 Habits to Embrace the Joy of Missing Out: https://youtu.be/DIJXnrmslz8 LISTEN to episode 082 of the Productivity Paradox podcast for more: https://ppx.inkwellpress.com/episode/… READ the Blog: → How to Build in Breaks to Your Work Schedule: https://wp.me/p9ZwEH-Ax → Got 2 minutes? Here’s 25 things you can do instead of scrolling your phone: https://wp.me/p9ZwEH-Av Say HELLO on social: Instagram: https://www.instagram.com/tonyadalton… Facebook: https://www.facebook.com/inkwellpress/ Twitter: https://twitter.com/inkwellpress Group: inkWELL Press Productivity Co. – Our supportive, private Facebook group for everything productivity: https://inkwellpress.com/group

New Technique From Cambridge Cancer Researchers Will Enable More Targeted Tumour Biopsies

Cancer researchers in Cambridge have developed an advanced computing technique using routine medical scans that could enable doctors to take fewer, but more accurate, tumour biopsies.

They have combined CT (computed tomography) scans with ultrasound images to create a visual guide for medics that enables them to use more targeted biopsies to sample the full complexity of a tumour.

One day the technique could even allow clinical biopsies to be replaced with virtual biopsies, to spare patients invasive procedures.

The research was led by Professor Evis Sala, from the Department of Radiology, co-lead of the Cancer Research UK Cambridge Centre’s advanced cancer imaging programme, who said: “This study provides an important milestone towards precision tissue sampling. We are truly pushing the boundaries in translating cutting-edge research to routine clinical care.”

Most cancer patients undergo one or several biopsies in order to capture their tumour’s heterogeneity – that is the full genetic variety of cells within it.

Understanding this is key for selecting the best treatment, as genetically different cells may respond differently to therapies.

Reducing the number of these biopsies, and ensuring they accurately sample the different cells is therefore crucial, particularly for ovarian cancer patients.

High grade serous ovarian (HGSO) cancer is the most common type of ovarian cancer and referred to as a ‘silent killer’ because its early symptoms can be hard to pick up. Survival rates have not improved much in 20 years.

HGSO tumours also have a high level of heterogeneity – and we know that patients with more genetically-different patches cancer cells tend to have poorer responses to treatment.

Top Stories on Cambridge Independent

Prof Sala leads a multi-disciplinary team of radiologists, physicists, oncologists and computational scientists using innovative computing techniques to reveal tumour heterogeneity from standard medical images.

The new study involved a small group of patients with advanced ovarian cancer, who were due to have ultrasound-guided biopsies prior to starting a course of chemotherapy.

Patients in the study first had a standard CT scan, which uses X-rays and computing to create a 3D image of the tumour, by taking multiple image ‘slices’ through the body.

The process of radiomics, which uses high-powered computing to analyse and extract additional information from the data-rich CT scan images, was then used to identify and map distinct areas and features of the tumour.

The researchers then superimposed the ultrasound image of the tumour and the combined image – which successfully captured the diversity of cancer cells – was used to guide the biopsy procedure.

Co-first author Dr Lucian Beer, from the Department of Radiology and CRUK Cambridge Centre ovarian cancer programme, said: “Our study is a step forward to non-invasively unravel tumour heterogeneity by using standard-of-care CT-based radiomic tumour habitats for ultrasound-guided targeted biopsies.”

Co-first author Paula Martin-Gonzalez, also from the programme, added: “We will now be applying this method in a larger clinical study.”

The study was welcomed by Fiona Barve, 56, a science teacher living near Cambridge, who was diagnosed with stage 4 ovarian cancer in 2017 after visiting her doctor with abdominal pain. She immediately underwent surgery and chemotherapy and has been cancer-free since March 2019.

Fiona, who is now back to teaching three days a week, said: “I was diagnosed at a late stage and I was fortunate my surgery, which I received within four weeks of being diagnosed, and chemotherapy worked for me. I feel lucky to be around.

“When you are first undergoing the diagnosis of cancer, you feel as if you are on a conveyor belt, every part of the journey being extremely stressful. This new enhanced technique will reduce the need for several procedures and allow patients more time to adjust to their circumstances. It will enable more accurate diagnosis with less invasion of the body and mind. This can only be seen as positive progress.”

The feasibility study involved researchers from the Department of Radiology, CRUK Cambridge Institute, Addenbrooke’sl, Cambridge University Hospitals NHS Foundation Trust and collaborators at Cannon, and was facilitated through the CRUK Cambridge Centre Integrated Cancer Medicine programme.

The progamme’s aim is to revolutionise cancer treatment using the integration of complex patient data from multiple sources – blood tests, biopsies, medical imaging, and genetic tests – to inform and predict the best treatment decisions for each individual.

The study was funded by Cancer Research UK and The Mark Foundation for Cancer Research.

Read more

The breast cancer scan developed by CRUK Cambridge Institute that could replace invasive tissue biopsies

Babraham Institute study of Oxford University’s Covid-19 vaccine underscores importance of second dose

By Paul Brackley

.

.

Phospho Biomedical Animation

Being able to easily track cancer is vital in all stages of the disease. Doctors have long been able to monitor the disease with scans and by taking small tissue samples (biopsies), but now a new technique is becoming available to them: the liquid biopsy, which can deliver a lot of detailed information about a patient’s tumour from a simple blood sample. So how does it work? Inside a tumour, cells are growing at a high rate, but while many cancer cells are growing, some are also dying in a process called apoptosis. As dying cancer cells break up, they release fragments of their DNA. Some of that DNA can get into the blood stream, after which it’s called circulating tumour DNA (or ctDNA). This circulating tumour DNA is ready for scientists to fish out with a simple blood sample. Because of advances in DNA sequencing technology, doctors can pick up on these traces of DNA, and use them to track the mutations present in a cancer. Finding out this information helps doctors keep track of a patient’s tumour and whether treatment is working, or find out early if a new scan or different treatment is needed. For more information, see http://scienceblog.cancerresearchuk.o…http://scienceblog.cancerresearchuk.o..

6 Conditions That Cause Nasal Polyps

Do you feel like you’ve caught a never-ending cold or a sinus infection that keeps coming back? There may be more going on in your nose than you think. Your symptoms may be caused by nasal polyps: soft, painless growths that hang down like teardrops on the lining of your nasal passages or sinuses. These pile on inflammation and block airways. Nasal polyps are not cancer, but they do need to be addressed. Learn about conditions that can contribute to or cause nasal polyps and have an informed conversation with your doctor about diagnosis and treatment.

1. Chronic Sinusitis

If your “sinus infection” goes on for weeks and months, you may have chronic sinusitis, also known as chronic rhinosinusitis or CRS. This condition puts you at greater risk of nasal polyps. In fact, about 20% of the millions of people around the world with chronic sinusitis also have nasal polyps. Chronic rhinosinusitis with nasal polyps (CRSwNP) most often affects people in their 30s and 40s, but it can affect anyone of any age. Tell your doctor if you have a stuffy or runny nose, sinus pressure, or loss of smell or taste for 10 days or more. 

2. Asthma

Up to 39% of those with adult-onset asthma also have nasal polyps. The medical term for having nasal polyps and asthma is “nasal polyps and comorbid asthma,” or “NPcA.” NPcA is considered a severe united airway disease. While having asthma puts you at higher risk of developing nasal polyps, the connection goes both ways: up to 45% of those with nasal polyps go on to develop adult-onset asthma. Anyone with asthma should have regular touchpoints with their doctor to ensure good asthma control, including appropriate management of related conditions.

3. Nasal Allergies

A nasal allergy, or allergic rhinitis, causes inflammation in the nose that can lead to nasal polyps. There are two main types of allergic rhinitis. Seasonal allergic rhinitis, or hay fever, is triggered by pollen from grass, weeds, and trees, usually in the spring and fall.  Perennial allergic rhinitis is triggered by animal dander, mold, and dust mites year-round. Symptoms of allergic rhinitis are like the common cold, but they last longer and tend to involve more itchiness in the nose and eyes.

4. Allergic Fungal Sinusitis

Fungi in the environment can cause allergic fungal sinusitis (AFS). Like a nasal allergy, fungi cause inflammation in the nose. They also slow or block the drainage of mucus from the sinuses. AFS can lead to both nasal polyps and chronic sinusitis. One sign of AFS is thick, sticky mucus. Your doctor can take a quick sample of your mucus and test it for AFS. A proper diagnosis is important, because AFS can damage your eyesight and sense of smell if it’s not treated. You can develop allergic fungal sinusitis at any age, but it’s more common in teenagers and young adults.   

5. Aspirin Sensitivity

Aspirin sensitivity can cause life-threatening breathing problems that may exacerbate nasal inflammation and encourage nasal polyps to form. If you have a sensitivity to aspirin or another non-steroidal anti-inflammatory drug (NSAID), plus chronic sinusitis, plus asthma, you have what’s known as aspirin-exacerbated respiratory disease (AERD). Other common names for the condition are ASA Triad and Sampter’s Triad. Some people with the condition benefit from aspirin desensitization. It’s a process in which your doctor exposes you to a small dose of aspirin that is increased gradually to raise your tolerance until your sensitivity is gone.

6. Cystic Fibrosis

Cystic fibrosis, or CF, is a genetic disorder that causes mucus to build up in the body and block the airways. This leads to lung infections, breathing problems, and nasal polyps. Nasal polyps develop in up to 60% of people who have cystic fibrosis. Doctors can use a few different tests to diagnosis cystic fibrosis, and 75% of people who have it are diagnosed by the time they’re two years old.

There’s a lot to learn about what’s causing your nasal discomfort and polyps. Fortunately, there are also lots of treatments that can give you relief. Look for a doctor who will listen to your unique experience and work through the complexities of your specific case with you. Was this helpful?

Evelyn Creekmore Evelyn Creekmore has more than 15 years of experience writing online educational health content, including nearly 10 years full-time at WebMD, where she was the director of brand content. She holds an MPH in Applied Public Health Informatics from Emory University Rollins School of Public Health and an MA from the University of North Carolina at Charlotte. Medical Reviewer: William C. Lloyd III, MD, FACS Last Review Date: 2020 Mar 19

.

.

.

Nebraska Medicine Nebraska Medical Center

Dr. Christie Barnes, an ENT specialist, at Nebraska Medicine discusses what nasal polyps are, how they form and what treatment options are available. For more about Dr. Barnes: http://doctors.nebraskamed.com/doctor…

Why Scientists & Public Health Officials Need To Address Vaccine Mistrust Instead of Dismissing it

Recent polls indicate that more than a third of the country has concerns about a vaccine that in all likelihood will be the only reliable way to end to the COVID-19 pandemic.

These results reflect a similar public sentiment in the U.S. in the 1950s when a polio vaccine was introduced. There are likely multiple reasons for this suspicion, including safety concerns, lack of transparency from the scientific community, lack of trust in the government and the desire to wait until a longer track record of safety can be established.

We are experts in media literacy, health and political communication and biostatistics and biomedical research for future health care providers, from Washington State University’s Edward R. Murrow Center for Media & Health Promotion Research and the Elson S. Floyd College of Medicine. We also live in the communities we hope to serve with our science.

Based on our research, we believe that officials need to use this testing period to build trust, not to create reasons for diminishing it. Respect and forthrightness can turn the tone from adversarial to collaborative, and from a provider-directed practice to a shared decision-making process. Scientists and public health officials must anticipate and address people’s concerns and not brush aside concerns, a process that has become commonplace across other areas of the provider-patient relationship, but vaccine decisions remain a notable exception.

Vaccines and complications

Vaccines are among the safest, most transformative drugs on Earth, with adverse events so low that very nearly universal vaccination is a reasonable expectation. With such a safety record, and with so much at risk with diseases like COVID-19, measles and influenza, vaccine advocates have good reason to stress the overwhelmingly positive safety record.

History has included some vaccines of questionable quality as well as vaccination tactics of even more concern. Certain minority groups have been targeted with egregious coercion. This included cases of forced vaccination for smallpox of African Americans at gunpoint in the southern United States in the early 1900s. At a tenement house in Manhattan’s Little Italy, over 200 men in 1901 in essence performed a smallpox vaccination raid in the middle of the night, trying to vaccinate as many people as they could.

When the miracle vaccine for polio was widely distributed in 1955, speed took precedent over safety, and many doses were distributed that contained live polio virus. As a result, 70,000 children developed muscle weakness, 164 were paralyzed permanently and 10 children died. This led to direct government intervention that has led to thousands of required tests in order to ensure safety and effectiveness.

Why can’t vaccines bounce back from mistakes?

As medical and public health researchers, we have found it interesting that corporations that have been lax and dishonest have bounced back without lasting damage to their reputations. For example, Volkswagen was caught in 2014 for outright lying to the public about their emissions. By 2019, the company topped its prescandal sales record of 2014.

We accept these occasionally fatal flaws and ethical missteps because cars are essential to our lives. The documented safety record of vaccines is staggering, not unlike the impressive safety record boasted by most automobiles on the road today.

Why do vaccines get special scrutiny? Have scientists and health care providers engaged in scientific snobbery by assuming people should do what we advise, without question or any decision-making process? Can scientists and health care providers communicate the good and positive (and bad) background of vaccines better? Has social media sown doubt in an authority that can be perceived to be overconfident? Personal health care decisions have a lasting impact on our kids and our families, so let’s rise to the occasion and utilize this unique opportunity to reframe the conversation about vaccines.

Embrace shared decision-making

The existence of a little-known but critical government office both acknowledges past problems with some vaccines and also provides a method of recourse for those injured by vaccines. The National Vaccine Injury Compensation Program, launched in the 1980s, is a powerful tool for transparency and accountability that should help shape this important, shared decision-making process. For example, between 2006 and 2018 over 3.7 billion doses of covered vaccines were distributed in the U.S. During this same period, 5,233 filed petitions to this office were compensated out of a total of 7,482 petitions. This means that for every 1 million vaccine doses distributed, one individual received compensation.

Rather than brushing off concerns among parents and others who are concerned about safety, experts should listen. When they do talk, they should explain safety issues and should use metaphors such as the safety of vehicles and other medical breakthroughs (e.g., insulin, heart valve surgery) so often relied upon in an effort to work toward the same goal together as a country, and as health care provider and patient.

Experts should acknowledge that the practice of medicine and public health research is a relatively new field of science to drive public health, medical practice advancement and policies when compared to other, far more established scientific disciplines such as physics or chemistry. Building public support requires more than citing solid evidence in the peer-reviewed scientific literature. Owning up to setbacks in vaccine development that the current administration may be on the brink of repeating – and then making the necessary repairs to move forward again, as the auto manufacturers do – also builds confidence. AstraZeneca’s public announcement about a serious adverse event in one of their trials, which led to a pause of participant enrollment, was a great first step.

Let’s begin by acknowledging that all parties want to achieve the same end goal of a healthy, safe return to daily life. Despite the explosion of misinformation about COVID-19, a clear, consistent and respectful approach can reset the vaccine conversation.

[Deep knowledge, daily. Sign up for The Conversation’s newsletter.]

Next, let’s acknowledge that vaccines are not now and have not been 100% perfect (nor is any medicine or car). We should also note that the same science that produces vaccines also produces myriad breakthroughs in specialties such as cardiology and oncology, along with over-the-counter medications such as ibuprofen that mitigate minor ailments but also have limitations and warning labels.

Finally, invite skeptics to a conversation and acknowledge up front that, like any other scientific advancement of things that now work, there was a time when they didn’t work as well, or at all.

Instances like these undoubtedly fuel people’s concerns. Such occurrences should give us all pause, scientist or not, to do better next time and strive to never repeat such notable grievances.

By: Sterling M. McPherson/ Associate Professor, Director and Assistant Dean for Research, Washington State University

Erica Weintraub Austin/ Professor and Director, Edward R. Murrow Center for Media & Health Promotion Research, Washington State University

Porismita Borah/Associate Professor, health communication, Washington State University

.

.

CBC News: The National

Misinformation about vaccines have public health officials in Canada looking for guidance on how to combat medical mistrust. As CBC’s Katie Nicholson reports, the answers they are looking for might be half a world away. »»» Subscribe to The National to watch more videos here: https://www.youtube.com/user/CBCTheNa… Voice Your Opinion & Connect With Us Online: The National Updates on Facebook: https://www.facebook.com/thenational The National Updates on Twitter: https://twitter.com/CBCTheNational »»» »»» »»» »»» »»» The National is CBC Television’s flagship news program. Airing six days a week, the show delivers news, feature documentaries and analysis from some of Canada’s leading journalists.

%d bloggers like this: